<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">86269</article-id><article-id pub-id-type="doi">10.7554/eLife.86269</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group></article-categories><title-group><article-title>Apoptosis recognition receptors regulate skin tissue repair in mice</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-303899"><name><surname>Justynski</surname><given-names>Olivia</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-0774-5983</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund6"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-305115"><name><surname>Bridges</surname><given-names>Kate</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-3642-7068</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-305116"><name><surname>Krause</surname><given-names>Will</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-7585-5749</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-62324"><name><surname>Forni</surname><given-names>Maria Fernanda</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3335-9023</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-194440"><name><surname>Phan</surname><given-names>Quan M</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-305117"><name><surname>Sandoval-Schaefer</surname><given-names>Teresa</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-341512"><name><surname>Carter</surname><given-names>Kristyn</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-341513"><name><surname>King</surname><given-names>Diane E</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-341514"><name><surname>Hsia</surname><given-names>Henry C</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-341515"><name><surname>Gazes</surname><given-names>Michael I</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-341516"><name><surname>Vyce</surname><given-names>Steven D</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-193023"><name><surname>Driskell</surname><given-names>Ryan R</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-7673-2564</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-69463"><name><surname>Miller-Jensen</surname><given-names>Kathryn</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-7233-0100</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund7"/><xref ref-type="other" rid="fund8"/><xref ref-type="other" rid="fund9"/><xref ref-type="fn" rid="con13"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-6760"><name><surname>Horsley</surname><given-names>Valerie</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-1254-5839</contrib-id><email>valerie.horsley@yale.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con14"/><xref ref-type="fn" rid="conf2"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03v76x132</institution-id><institution>Dept. of Molecular Cellular and Developmental Biology, Yale University</institution></institution-wrap><addr-line><named-content content-type="city">New Haven</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03v76x132</institution-id><institution>Dept. of Biomedical Engineering, Yale University</institution></institution-wrap><addr-line><named-content content-type="city">New Haven</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05dk0ce17</institution-id><institution>Washington State University, SMB</institution></institution-wrap><addr-line><named-content content-type="city">Pullman</named-content></addr-line><country>United States</country></aff><aff id="aff4"><label>4</label><institution>Sunnycrest Bioinformatics</institution><addr-line><named-content content-type="city">Flemington</named-content></addr-line><country>United States</country></aff><aff id="aff5"><label>5</label><institution>Dept. of Surgery (Plastic), Yale School of Medicine</institution><addr-line><named-content content-type="city">New Haven</named-content></addr-line><country>United States</country></aff><aff id="aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05tszed37</institution-id><institution>Dept of Podiatric Surgery, Yale New Haven Hospital</institution></institution-wrap><addr-line><named-content content-type="city">New Haven</named-content></addr-line><country>United States</country></aff><aff id="aff7"><label>7</label><institution>Dept. of Dermatology, Yale School of Medicine</institution><addr-line><named-content content-type="city">New Haven</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Jamora</surname><given-names>Colin</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/007wpch15</institution-id><institution>Institute for Stem Cell Biology and Regenerative Medicine</institution></institution-wrap><country>India</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Rath</surname><given-names>Satyajit</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00djv2c17</institution-id><institution>Indian Institute of Science Education and Research (IISER)</institution></institution-wrap><country>India</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>21</day><month>12</month><year>2023</year></pub-date><pub-date pub-type="collection"><year>2023</year></pub-date><volume>12</volume><elocation-id>e86269</elocation-id><history><date date-type="received" iso-8601-date="2023-01-18"><day>18</day><month>01</month><year>2023</year></date><date date-type="accepted" iso-8601-date="2023-11-17"><day>17</day><month>11</month><year>2023</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at bioRxiv.</event-desc><date date-type="preprint" iso-8601-date="2023-01-17"><day>17</day><month>01</month><year>2023</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2023.01.17.523241"/></event></pub-history><permissions><copyright-statement>© 2023, Justynski et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Justynski et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-86269-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-86269-figures-v1.pdf"/><abstract><p>Apoptosis and clearance of apoptotic cells via efferocytosis are evolutionarily conserved processes that drive tissue repair. However, the mechanisms by which recognition and clearance of apoptotic cells regulate repair are not fully understood. Here, we use single-cell RNA sequencing to provide a map of the cellular dynamics during early inflammation in mouse skin wounds. We find that apoptotic pathways and efferocytosis receptors are elevated in fibroblasts and immune cells, including resident Lyve1<sup>+</sup> macrophages, during inflammation. Interestingly, human diabetic foot wounds upregulate mRNAs for efferocytosis pathway genes and display altered efferocytosis signaling via the receptor <italic>Axl</italic> and its ligand <italic>Gas6</italic>. During early inflammation in mouse wounds, we detect upregulation of Axl in dendritic cells and fibroblasts via TLR3-independent mechanisms. Inhibition studies in vivo in mice reveal that Axl signaling is required for wound repair but is dispensable for efferocytosis. By contrast, inhibition of another efferocytosis receptor, Timd4, in mouse wounds decreases efferocytosis and abrogates wound repair. These data highlight the distinct mechanisms by which apoptotic cell detection coordinates tissue repair and provides potential therapeutic targets for chronic wounds in diabetic patients.</p></abstract><abstract abstract-type="plain-language-summary"><title>eLife digest</title><p>Our skin is constantly exposed to potential damage from the outside world, and it is vital that any injuries are repaired quickly and effectively. Diabetes and many other health conditions can hamper wound healing, resulting in chronic wounds that are both painful and at risk of becoming infected, which can lead to serious illness and death of patients.</p><p>After an injury to the skin, the wound becomes inflamed as immune cells rush to the site of injury to fight off infection and clear the wound of dead cells and debris. Some of these dead cells will have died by a highly controlled process known as apoptosis. These so-called apoptotic cells display signals on their surface that nearby healthy cells recognize. This triggers the healthy cells to eat the apoptotic cells to remove them from the wound. Previous studies have linked changes in cell death and the removal of dead cells to chronic wounds in patients with diabetes, but it remains unclear how removing dead cells from the wound affects healing.</p><p>Justynski et al. used a genetic technique called single-cell RNA sequencing to study the patterns of gene activity in mouse skin cells shortly after a wound. The experiments found that, as the area around the wound started to become inflamed, the wounded cells produced signals of apoptosis that in turn triggered nearby healthy cells to remove them. Other signals relating to the removal of dead cells were also widespread in the mouse wounds and treating the wounds with drugs that inhibit these signals resulted in multiple defects in the healing process.</p><p>Further experiments used the same approach to study samples of tissue taken from foot wounds in human patients with or without diabetes. This revealed that several genes involved in the removal of dead cells were more highly expressed in the wounds of diabetic patients than in the wounds of other individuals.</p><p>These findings indicate that for wounds to heal properly it is crucial for the body to detect and clear apoptotic cells from the wound site. Further studies building on this work may help to explain why some diabetic patients suffer from chronic wounds and help to develop more effective treatments for them.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>wound healing</kwd><kwd>apoptosis</kwd><kwd>efferocytosis</kwd><kwd>skin</kwd><kwd>repair</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010848</institution-id><institution>Gruber Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Justynski</surname><given-names>Olivia</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>Predoctoral Training Program in Cellular and Molecular Biology</award-id><principal-award-recipient><name><surname>Justynski</surname><given-names>Olivia</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000069</institution-id><institution>National Institute of Arthritis &amp; Musculoskeletal &amp; Skin Diseases</institution></institution-wrap></funding-source><award-id>R01 AR079232</award-id><principal-award-recipient><name><surname>Justynski</surname><given-names>Olivia</given-names></name><name><surname>Krause</surname><given-names>Will</given-names></name><name><surname>Forni</surname><given-names>Maria Fernanda</given-names></name><name><surname>Sandoval-Schaefer</surname><given-names>Teresa</given-names></name><name><surname>Carter</surname><given-names>Kristyn</given-names></name><name><surname>Horsley</surname><given-names>Valerie</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000069</institution-id><institution>National Institute of Arthritis &amp; Musculoskeletal &amp; Skin Diseases</institution></institution-wrap></funding-source><award-id>R01 AR075412</award-id><principal-award-recipient><name><surname>Justynski</surname><given-names>Olivia</given-names></name><name><surname>Krause</surname><given-names>Will</given-names></name><name><surname>Forni</surname><given-names>Maria Fernanda</given-names></name><name><surname>Carter</surname><given-names>Kristyn</given-names></name><name><surname>Sandoval-Schaefer</surname><given-names>Teresa</given-names></name><name><surname>Horsley</surname><given-names>Valerie</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000069</institution-id><institution>National Institute of Arthritis &amp; Musculoskeletal &amp; Skin Diseases</institution></institution-wrap></funding-source><award-id>R01 AR076938</award-id><principal-award-recipient><name><surname>Justynski</surname><given-names>Olivia</given-names></name><name><surname>Krause</surname><given-names>Will</given-names></name><name><surname>Forni</surname><given-names>Maria Fernanda</given-names></name><name><surname>Carter</surname><given-names>Kristyn</given-names></name><name><surname>Sandoval-Schaefer</surname><given-names>Teresa</given-names></name><name><surname>Horsley</surname><given-names>Valerie</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>T32 T32GM007223</award-id><principal-award-recipient><name><surname>Justynski</surname><given-names>Olivia</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>U01-CA238728</award-id><principal-award-recipient><name><surname>Miller-Jensen</surname><given-names>Kathryn</given-names></name></principal-award-recipient></award-group><award-group id="fund8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01-CA238728</award-id><principal-award-recipient><name><surname>Miller-Jensen</surname><given-names>Kathryn</given-names></name></principal-award-recipient></award-group><award-group id="fund9"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01-GM123011</award-id><principal-award-recipient><name><surname>Miller-Jensen</surname><given-names>Kathryn</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>After an injury to the skin, murine wounds upregulate apoptosis and efferocytosis pathways, which are required for effective healing and may similarly impact wound healing in diabetic patients.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Proper tissue function and homeostasis require efficient and effective repair of injury. Repair of mammalian tissues requires highly dynamic changes in cellular heterogeneity and communication to correctly heal tissue, usually resulting in a scar rather than true tissue regeneration. Cell death is a common event during tissue injury, and several studies from hydra to mice have shown the importance of apoptosis in the initiation of inflammation to drive reparative processes (<xref ref-type="bibr" rid="bib15">Greenhalgh, 1998</xref>). Proper initiation and subsequent resolution of inflammation is essential for tissue repair and progression to the proliferation stage of healing, when fibroblasts, blood vessels, and other tissue-specific cells proliferate and migrate, forming new tissue to repair the wound. While several signaling factors have been shown to induce apoptosis in wounds (<xref ref-type="bibr" rid="bib16">Guerin et al., 2021</xref>), the mechanisms by which apoptotic cells are recognized and regulate tissue repair are not well understood.</p><p>The skin is an excellent model to define the mechanisms by which apoptotic cells regulate tissue repair. After injury, mammalian skin undergoes stages of repair beginning with inflammation, which removes debris and pathogens. As inflammation regresses, the proliferative phase leads to the coordination of epidermal keratinocytes, fibroblasts, endothelial, and immune cells to reseal the epidermal barrier and generate a reparative scar including new ECM production and revascularization (<xref ref-type="bibr" rid="bib12">Eming et al., 2014</xref>). Apoptosis occurs after skin injury, and phagocytosis of apoptotic cells – or efferocytosis – by macrophages reduces inflammatory signaling and repair in several tissues (<xref ref-type="bibr" rid="bib4">Bosurgi et al., 2017a</xref>; <xref ref-type="bibr" rid="bib33">Peiseler and Kubes, 2019</xref>). Yet, it is unclear how apoptosis controls skin wound healing.</p><p>Apoptotic cell death is characterized by cytomorphological alterations, DNA fragmentation, activation of caspases and other regulators, and finally membrane alterations including outer membrane exposure of phosphatidylserine (PtdSer), which allows the recognition of apoptotic cells by cellular receptors on phagocytes (<xref ref-type="bibr" rid="bib11">Elmore, 2007</xref>). The most well-studied receptors that allow phagocytes to bind and phagocytose apoptotic cells include the TAM (Tyro3, Axl, and Mertk) tyrosine kinases and the TIM (T cell immunoglobulin and mucin domain) family of receptors (<xref ref-type="bibr" rid="bib23">Lemke, 2019</xref>). While TIM receptors can directly bind PtdSer, TAM receptors require their ligands growth-arrest-specific 6 (Gas6) and protein S (Pros1) to bind to PtdSer (<xref ref-type="bibr" rid="bib24">Lew et al., 2014</xref>; <xref ref-type="bibr" rid="bib10">Elliott et al., 2017</xref>).</p><p>To understand the cellular and molecular mechanisms by which apoptosis regulates skin wound healing, we performed single-cell RNA sequencing (scRNA-seq) on cells from murine wound beds 24 hr and 48 hr after injury. We found that transcriptional alterations in apoptotic pathways occur in this interval in fibroblasts, monocytes/macrophages, neutrophils, and dendritic cells. In addition, inhibition of two efferocytosis receptors, Axl and Timd4, abrogates proper wound repair. The results provide an atlas of cellular dynamics during the early stages of wound healing and reveal the essential role of the recognition and clearance of apoptotic cells in driving tissue repair after injury.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Dramatic transcriptional heterogeneity during early skin inflammation after injury</title><p>To assess cellular and molecular heterogeneity of the wound bed during the inflammatory phase, we performed scRNA-seq on cells isolated from 4 mm full-thickness biopsy punches on mouse back skin at 24 hr and 48 hr after injury (<xref ref-type="bibr" rid="bib41">Shook et al., 2016</xref>). To ensure that we also captured the immediately adjacent tissue as well as cells that may have migrated into the wound site, we used a 6 mm biopsy punch to collect the tissue before isolating cells using enzymatic digestion (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). By training a neural network to identify cell types based on expression of established marker genes (as in <xref ref-type="bibr" rid="bib47">Wasko et al., 2022</xref>; <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A–B</xref>), we classified four major cell types in the scRNA-seq data, including monocytes/macrophages (Mono/MO), neutrophils (Neut), dendritic cells (DC), and fibroblasts (FB) at both timepoints (<xref ref-type="fig" rid="fig1">Figure 1B–E</xref>).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Dynamic transcriptional heterogeneity and apoptosis are observed in murine wound beds 24 hr and 48 hr after injury.</title><p>(<bold>A</bold>) Schematic of experimental design. (<bold>B</bold>) UMAP plot of single-cell RNA sequencing (scRNA-seq) data for cells from 24 hr wound beds in murine back skin. (<bold>C</bold>) UMAP plot of scRNA-seq data for cells from 48 hr wound beds in murine back skin. (<bold>D</bold>) UMAP plot of scRNA-seq data for cells from both 24 hr and 48 hr wound beds in murine back skin annotated by timepoint. (<bold>E</bold>) Top: UMAP plot of scRNA-seq data for cells from 24 hr and 48 hr wound beds annotated by cell identity. Bottom: Heatmap of differentially expressed marker genes in 24 hr and 48 hr wound beds. (<bold>F</bold>) Gene ontology terms enriched in each cell type compared to the full dataset. (<bold>G</bold>) Heatmap of differentially expressed apoptosis-related genes from 24 hr and 48 hr wound beds. (<bold>H</bold>) Immunostaining for cleaved caspase 3 (Act. Casp3) (green) in wound bed 24 hr after injury. Arrow indicates cleaved caspase 3<sup>+</sup> cells. (<bold>I</bold>) Immunostaining for CD11c (green) and cleaved caspase 3 (red) in wound bed 24 hr after injury. Arrows indicate double-positive CD11c<sup>+</sup> cleaved caspase 3<sup>+</sup> cells. (<bold>J</bold>) Immunostaining for GFP (green) and cleaved caspase 3 (red) in <italic>Pdgfra</italic>CreER;mTmG wound bed 24 hr after injury. Arrow indicates double-positive GFP<sup>+</sup> cleaved caspase 3<sup>+</sup> cells. * indicates scab. Scale bars = 500 µm. In E and G, expression indicates scaled log-normalized mRNA counts.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-86269-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Dynamic cellular heterogeneity and evidence of apoptosis is observed in 24 hr and 48 hr wound beds by single-cell RNA sequencing (scRNA-seq).</title><p>(<bold>A</bold>) UMAP plot of scRNA-seq data for cells from 24 hr and 48 hr wound beds in murine back skin annotated by cell identity. (<bold>B</bold>) Feature plots showing expression of two marker genes for each major cell type. (<bold>C</bold>) Number of cells identified by cell type at 24 hr and 48 hr. (<bold>D</bold>) Proportion of total cells represented by 24 hr or 48 hr for each major cell type. (<bold>E</bold>) Venn diagrams representing significantly upregulated genes shared by both timepoints or specific to 24 hr or 48 hr for each major cell type. (<bold>F</bold>) Top, Bottom left: Immunostaining for cleaved caspase 3 (green) in 48 hr wound bed. Arrow indicates cleaved caspase 3<sup>+</sup> cell. * indicates scab. Scale bar = 500 µm. Bottom right: Quantification of cleaved caspase 3<sup>+</sup> cells per mm<sup>2</sup> in the wound bed. *p&lt;0.05.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-86269-fig1-figsupp1-v1.tif"/></fig></fig-group><p>Surprisingly, the 24 hr and 48 hr samples clustered separately with minimal overlap, suggesting that dramatic changes occurred in the first 2 days of inflammation (<xref ref-type="fig" rid="fig1">Figure 1B–D</xref>). The absolute number of macrophages and neutrophils increased &gt;2-fold over this interval (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C</xref>). While approximately 70% of each of the three immune cell populations was collected at 48 hr, the majority of fibroblasts were found in the 24 hr population (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1D</xref>). We also found that genes upregulated by each cell type were markedly different between timepoints (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1E</xref>), indicating major changes to expression patterns in the same cell type over time.</p><p>To explore the changes in the major cell types in early wound beds (fibroblasts, neutrophils, DCs, and monocytes/macrophages), we analyzed the genes that were significantly upregulated in each group relative to the mRNAs expressed by the full dataset to determine gene ontology (GO) terms that were enriched for each cell type (<xref ref-type="fig" rid="fig1">Figure 1F</xref>). Monocytes/macrophages, neutrophils, and DCs upregulated mRNAs involved in their specific function in inflammation for cytokine production, chemotaxis, and antigen presentation, respectively. Similarly, fibroblasts uniquely upregulated genes involved in extracellular matrix (ECM) organization. Interestingly, DCs, fibroblasts, and neutrophils upregulated genes involved in apoptosis and cell death (<xref ref-type="fig" rid="fig1">Figure 1F and G</xref>). Neutrophils upregulated the largest number of mRNAs for apoptosis including <italic>Casp3</italic>, which is cleaved to activate apoptosis, and <italic>S100a8</italic> and <italic>S100a9</italic>, which induce apoptosis of several cell types (<xref ref-type="bibr" rid="bib51">Yui et al., 2003</xref>). Fibroblasts and DCs also upregulated apoptotic genes ranging from receptors (<italic>Fgfr1</italic> and <italic>Bmpr1a</italic>), cytokines (<italic>Il12b</italic>), to mediators of apoptotic pathways (<italic>Bcl2l14</italic> and <italic>Cth</italic>).</p><p>Since apoptosis also involves post-transcriptional activation of several proteins, we sought to confirm that apoptosis occurred during early skin wound inflammation in vivo. Sections of mouse wounds at 24 hr (<xref ref-type="fig" rid="fig1">Figure 1H</xref>) and 48 hr (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1F</xref>) were stained with antibodies (Abs) against cleaved (active) caspase 3 to detect activation of apoptosis. We found that significantly more cleaved caspase 3<sup>+</sup> cells were present in 48 hr wounds (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1F</xref>). We also detected cleaved caspase 3 in CD11c<sup>+</sup> dendritic cells (<xref ref-type="fig" rid="fig1">Figure 1I</xref>) and Pdgfra<sup>+</sup> fibroblasts (<xref ref-type="fig" rid="fig1">Figure 1J</xref>) in 24 hr wound beds. Overall, these data suggest that apoptosis occurs during inflammation after skin injury.</p></sec><sec id="s2-2"><title>Apoptosis recognition receptors, ligands, and downstream factors are expressed in the wound bed</title><p>Given the upregulation of mRNAs associated with apoptosis and the relatively low level of apoptotic cells in early wound beds, we hypothesized that efficient efferocytosis clears apoptotic cells during inflammation. Initially, we inspected mRNA levels of efferocytosis receptors, their ligands, and downstream factors in scRNA-seq data from 24 hr and 48 hr wounds (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). Interestingly, fibroblasts upregulated several genes encoding efferocytosis receptors (<italic>Tyro3</italic>, <italic>Axl</italic>, <italic>Itgav</italic>, and <italic>Slc7a11),</italic> as well as genes encoding for ligands <italic>Gas6</italic>, <italic>Pros1, C3, C4b,</italic> and <italic>Mfge8</italic>. DCs, macrophages, and neutrophils also upregulated several receptors that mediate detection of apoptotic cells. Macrophages were enriched for the downstream activators <italic>Arg1</italic> and <italic>Retnla</italic>, whereas other cell types upregulated <italic>Socs1</italic> and <italic>Socs3</italic>, which are downstream of the TAM receptors (<xref ref-type="bibr" rid="bib38">Rothlin et al., 2007</xref>).</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Apoptosis detection genes are highly expressed in the wound bed.</title><p>(<bold>A</bold>) Heatmap of differentially expressed efferocytosis pathway genes in 24 hr and 48 hr wound beds. Expression indicates scaled log-normalized mRNA counts. (<bold>B</bold>) Feature plots showing expression of <italic>Gas6, Lyve1, Timd4,</italic> and <italic>Retnla</italic> with <italic>Lyve1</italic><sup>+</sup> region highlighted. (<bold>C</bold>) Immunostaining for GFP (green) and Lyve1 (red) in <italic>Lyz2</italic>CreER;mTmG wound bed 24 hr after injury. Arrows indicate Lyve1<sup>+</sup> cells. (<bold>D</bold>) Immunostaining for Gas6 (green) and Lyve1 (red) in wild-type (WT) wound bed 24 hr after injury. Arrows indicate double-positive Gas6<sup>+</sup> Lyve1<sup>+</sup> cells. (<bold>E</bold>) Immunostaining for Timd4 (green) in WT wound bed 24 hr after injury. Arrows indicate Timd4<sup>+</sup> cells. (<bold>F</bold>) Immunostaining for CD11c (green) and Axl (red) in wound bed 24 hr after injury. Arrows indicate double-positive CD11c<sup>+</sup> Axl<sup>+</sup> cells. (<bold>G</bold>) Immunostaining for GFP (green) and Axl (red) in <italic>Pdgfra</italic>CreER;mTmG wound bed 24 hr after injury. Arrows indicate double-positive GFP<sup>+</sup> Axl<sup>+</sup> cells. (<bold>H</bold>) Schematic of experimental design. (<bold>I</bold>) Immunostaining for CFSE-stained apoptotic neutrophils in wound beds 1 and 5 days after injury. (<bold>J</bold>) Example of CFSE-stained whole neutrophil in the wound bed. Scale bar = 100 µm. (<bold>K</bold>) Example of active efferocytosis of CFSE-stained whole neutrophil in the wound bed. Scale bar = 100 µm. (<bold>L</bold>) Quantification of instances of efferocytosis observed per mm<sup>2</sup> in the wound bed. (<bold>M</bold>) Quantification of percentage of all stained cells that are undergoing efferocytosis in the wound bed. In L and M, n=6, error bars indicate mean ± SEM, unpaired t-test, *p&lt;0.05, **p&lt;0.01. * indicates scab. In C–I, scale bars = 500 µm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-86269-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Lyve1 and apoptosis receptors, ligands, and downstream factors are expressed in 24 hr and 48 hr wound beds.</title><p>(<bold>A</bold>) Immunostaining for GFP (green) and Lyve1 (red) in <italic>Lyz2</italic>CreERmTmG wound bed-adjacent skin 24 hr after injury. Arrows indicate Lyve1<sup>+</sup> cells, * indicates scab. Scale bar = 500 µm. (<bold>B</bold>) mRNA expression of genes relative to NW control at 24 hr and 48 hr after injury. Red line indicates normalized control mRNA levels. Error bars indicate mean ± SEM, n=3 independent experiments. Statistics using unpaired t-test are indicated; *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-86269-fig2-figsupp1-v1.tif"/></fig></fig-group><p>We noted that Axl’s ligand, <italic>Gas6</italic>, and several other genes involved in efferocytosis were expressed predominantly in the fibroblast cluster, but were also lowly expressed in the monocyte/macrophage cluster (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). Examining the UMAP plot to determine the heterogeneity of efferocytosis gene expression within individual cell types, we observed that <italic>Gas6</italic> was highly expressed by a specific subset of monocyte/macrophage cells. These cells also overexpressed the resident macrophage marker <italic>Lyve1</italic>, the apoptosis receptor <italic>Timd4,</italic> and <italic>Retnla,</italic> a downstream factor of efferocytosis (<xref ref-type="fig" rid="fig2">Figure 2B</xref>), indicating that they may play a role in apoptosis detection and response in wound healing. <italic>Lyve1</italic> has been identified as a marker for resident macrophages, which are distinct from the majority of wound macrophages that differentiate from bone marrow-derived monocytes and are recruited to the wound after injury (<xref ref-type="bibr" rid="bib27">Lim et al., 2018</xref>; <xref ref-type="bibr" rid="bib45">Wang et al., 2020</xref>). To confirm the presence of Lyve1<sup>+</sup> resident cells in vivo, we used a <italic>Lyz2</italic>CreER;mTmG mouse model, in which myeloid cells in the bone marrow can be induced to express GFP prior to injury, such that any GFP<sup>+</sup> cells observed in the wound bed are interpreted as newly recruited to the site of injury, while GFP<sup>-</sup> cells are interpreted to be resident to the skin. We observed that Lyve1 was expressed at the protein level both in wound beds (<xref ref-type="fig" rid="fig2">Figure 2C</xref>) and adjacent to the wound (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>) with immunofluorescence staining, and confirmed that these cells were resident rather than recruited to the wound bed after injury, since they did not express GFP. Further, we confirmed that Lyve1<sup>+</sup> cells co-expressed Gas6 protein (<xref ref-type="fig" rid="fig2">Figure 2D</xref>) and that Timd4 protein (<xref ref-type="fig" rid="fig2">Figure 2E</xref>) was expressed in wound beds.</p><p>The TAM receptor <italic>Axl</italic> was uniquely expressed in the single-cell dataset by both dendritic cells and fibroblasts (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). Using immunofluorescence staining, we confirmed Axl expression in 24 hr wound beds in both dendritic cells (CD11c) (<xref ref-type="fig" rid="fig2">Figure 2F</xref>) and fibroblasts (Pdgfra-GFP) (<xref ref-type="fig" rid="fig2">Figure 2G</xref>), which displayed elongated GFP<sup>+</sup> processes with central localization of Axl. Thus, while we cannot rule out Axl expression by other cell types in skin wounds, these data are consistent with our single-cell results, confirming that Axl is expressed by fibroblasts and dendritic cells during the inflammatory response of skin repair.</p><p>We also analyzed mRNA expression of apoptosis-related genes by qPCR to determine their expression in wound beds compared to naive skin (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>). All efferocytosis receptor mRNAs studied, including the TAM receptors, were significantly upregulated in the wound bed compared to naive skin, while the ligand <italic>Gas6</italic> was significantly downregulated. The downstream factor of efferocytosis <italic>Retnla</italic> was also significantly downregulated in the wound bed, while <italic>Socs1</italic> and <italic>Socs3</italic> were significantly upregulated.</p><p>To analyze efferocytosis activity after injury, we intradermally injected labeled apoptotic neutrophils from bone marrow into wound beds 1, 3, and 5 days after injury. Wound beds were collected 1 hr after injections, sectioned, and imaged to quantify labeled cells (<xref ref-type="fig" rid="fig2">Figure 2H</xref>). We detected and quantified labeled intact neutrophils and efferocytosed neutrophils in wounds at all three timepoints (<xref ref-type="fig" rid="fig2">Figure 2H–M</xref>). While wounds at 5 days had significantly more cells undergoing efferocytosis (<xref ref-type="fig" rid="fig2">Figure 2L</xref>), the efferocytosis rate was generally constant, with a slight but nonsignificant increase at 3 days (<xref ref-type="fig" rid="fig2">Figure 2J</xref>). Taken together, these data indicate that the machinery for multiple efferocytosis pathways are active in the inflammatory and proliferative stages of wound healing.</p></sec><sec id="s2-3"><title>Cell death signaling in human diabetic and non-diabetic wounds</title><p>We next set out to explore whether these apoptosis and efferocytosis-related pathways were also relevant in pathological states associated with dysregulated wound healing, such as diabetes. Previous studies have indicated that apoptosis is increased in diabetic wounds, including an elevation in apoptotic lymphocytes (<xref ref-type="bibr" rid="bib2">Arya et al., 2014</xref>). Additional studies have shown that hypoxic environments (such as those found in diabetic wounds) increase macrophage efferocytosis (<xref ref-type="bibr" rid="bib46">Wang et al., 2023</xref>), though other studies have indicated that macrophage efferocytosis is defective in diabetic wounds (<xref ref-type="bibr" rid="bib21">Khanna et al., 2010</xref>).</p><p>To analyze the expression of transcriptional changes in apoptosis and efferocytosis signaling in foot wounds, we analyzed genes in these categories in four non-diabetic and five diabetic human patients (to be published elsewhere). We found several alterations in the expression of mRNAs associated with apoptotic signaling pathways between non-diabetic and diabetic foot ulcers (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref>). Specifically, monocytes/macrophages increased expression of several apoptosis genes (including <italic>BCL2</italic>, <italic>FGFR3</italic>, <italic>FGFR1</italic>, <italic>CTH</italic>, <italic>CASP3</italic>, <italic>IL19</italic>, <italic>NME5</italic>, and <italic>S100A8</italic>/<italic>9</italic>) in diabetic foot ulcers compared to monocytes/macrophages in non-diabetic wounds.</p><p>When we compared the expression of genes associated with the efferocytosis pathway between non-diabetic and diabetic foot ulcers, we found a striking increase in overall expression of efferocytosis pathway genes in diabetic wounds compared to non-diabetic wounds (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). In particular, the expression of <italic>AXL</italic> increased in all cell types in diabetic wounds, while expression of its ligand <italic>GAS6</italic> increased in all cell types with the exception of basal keratinocytes and mast cells.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Human diabetic wounds have increased efferocytosis signaling expression compared to non-diabetic wounds.</title><p>(<bold>A</bold>) Heatmaps of differentially expressed genes related to efferocytosis in non-diabetic and diabetic wound beds. Expression indicates scaled log-normalized mRNA counts. (<bold>B</bold>) CellChat circle plot diagrams showing <italic>GAS6-AXL</italic> communication in non-diabetic and diabetic wound beds. (<bold>C</bold>) Left: Immunostaining for CD68 (green) and Gas6 (red) in non-diabetic foot wound. Right: Immunostaining for CD68 (green) and Gas6 (red) in diabetic foot ulcer. Scale bars = 50 µm. (<bold>D</bold>) Quantification of Gas6 corrected total fluorescence. Error bars indicate mean ± SEM. n=2 for Non-diabetic, and 6 for diabetic foot wound; ns, nonsignificant.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-86269-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Human diabetic wounds have altered apoptosis gene expression compared to non-diabetic wounds.</title><p>(<bold>A</bold>) Heatmaps of differentially expressed genes related to efferocytosis in non-diabetic and diabetic wound beds. Expression indicates scaled log-normalized mRNA counts.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-86269-fig3-figsupp1-v1.tif"/></fig></fig-group><p>To further investigate the <italic>AXL</italic>/<italic>GAS6</italic> signaling pathway, we analyzed these data with CellChat, which quantitatively infers intercellular signaling networks from scRNA-seq data (<xref ref-type="bibr" rid="bib20">Jin et al., 2021</xref>). This analysis revealed altered signaling between <italic>AXL</italic> and its ligand <italic>GAS6</italic> between the two groups. In non-diabetic patient wounds, <italic>GAS6</italic> expression by several cell types, including monocytes/macrophages and fibroblasts, stimulated signaling via <italic>AXL</italic> receptors on fibroblasts and pericytes. However, in diabetic patient wounds, <italic>GAS6</italic> and <italic>AXL</italic> expression was more robust in several cell types. Notably, monocytes/macrophages increased <italic>GAS6</italic> stimulation and newly expressed <italic>AXL</italic> to receive pathway signaling in diabetic wounds (<xref ref-type="fig" rid="fig3">Figure 3B</xref>).</p><p>To validate these findings, we stained sections of non-diabetic foot wounds and diabetic foot ulcers with Abs against Gas6 and CD68, a macrophage marker. Indeed, we found that Gas6 staining was more prevalent in diabetic skin sections, and that it colocalized with the macrophage marker (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). Further, when quantified via corrected total fluorescence (CTF), more Gas6 staining was observed in diabetic samples, though this was not significant. This supported the CellChat results, indicating that macrophages express Gas6 more highly in diabetic wounds. Taken together, these data indicate that diabetic wounds may activate and modulate <italic>GAS6-AXL</italic> signaling, and suggest a potential avenue for future research.</p></sec><sec id="s2-4"><title>TLR3 stimulation is sufficient, but not necessary, for <italic>Axl</italic> upregulation in skin</title><p>Next, we sought to examine the molecular mechanisms that induce <italic>Axl</italic> mRNA expression after injury. Prior work showed that <italic>Axl</italic> expression was induced by toll-like receptor 3 (TLR3) stimulation (<xref ref-type="bibr" rid="bib38">Rothlin et al., 2007</xref>) and that TLR3 is essential for skin wound repair (<xref ref-type="bibr" rid="bib28">Lin et al., 2011</xref>). Thus, we experimentally tested the role of TLR3 signaling in <italic>Axl</italic> expression in the skin. scRNA-seq of early wounds revealed that <italic>TLR</italic> mRNAs are highly expressed in neutrophils and macrophages with a few expressed in dendritic cells and fibroblasts (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). Interestingly, <italic>TLR3</italic> is unique among the TLRs in that it is expressed by both dendritic cells and fibroblasts, which also express high levels of <italic>Axl</italic> in the single-cell dataset (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). To determine if TLR3 stimulation upregulates <italic>Axl</italic> expression in the skin, we injected the synthetic double-stranded RNA polyinosinic:polycytidylic acid (poly(I:C)) or a PBS control in naive mouse back skin of either wild-type (WT) or TLR3 knockout (KO) mice. We collected the injection site and surrounding area after 2 hr and processed the skin samples for qPCR and immunostaining (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). We first analyzed cytokine mRNA expression, a target of TLR3 signaling that promotes inflammation (<xref ref-type="bibr" rid="bib38">Rothlin et al., 2007</xref>). While several inflammatory cytokines were not induced in skin injected with poly(I:C) (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>), interferon (IFN)-β (<italic>Ifnb</italic>) was upregulated in WT mice injected with poly(I:C) but not in the skin of <italic>TLR3</italic> KO mice (<xref ref-type="fig" rid="fig4">Figure 4C</xref>), confirming the specificity of poly(I:C) for activation of TLR3 in the skin (<xref ref-type="bibr" rid="bib1">Alexopoulou et al., 2001</xref>). Axl protein (<xref ref-type="fig" rid="fig4">Figure 4D</xref>) and mRNA (<xref ref-type="fig" rid="fig4">Figure 4E</xref>) were induced in naive skin upon poly(I:C) injection, and <italic>Axl</italic> mRNA induction and protein expression were abrogated in skin of <italic>TLR3</italic> KO mice (<xref ref-type="fig" rid="fig4">Figure 4E</xref> and <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B</xref>). Axl protein expression around the dermal injection site was quantified via CTF (<xref ref-type="fig" rid="fig4">Figure 4F</xref>), confirming these results. Taken together, these data indicate that TLR3 signaling is sufficient to activate <italic>Axl</italic> expression in naive skin.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>TLR3 signaling is sufficient to upregulate Axl in naive skin, but TLR3 is not required for Axl expression in the wound bed.</title><p>(<bold>A</bold>) Heatmap of differentially expressed TLR genes in 24 hr and 48 hr wound beds. Expression indicates scaled log-normalized mRNA counts. (<bold>B</bold>) Schematic of injection and collection protocol. (<bold>C</bold>) mRNA expression of interferon genes relative to respective PBS injection. Red line indicates normalized control mRNA levels. Error bars indicate mean ± SEM, unpaired t-test, n=4-6 mice; **p&lt;0.01. ns, nonsignificant. (<bold>D</bold>) Immunostaining for Axl (red) in naive back skin injected with PBS or Poly(I:C). Arrows indicate Axl<sup>+</sup> cells. * indicates injection site. (<bold>E</bold>) mRNA expression of <italic>Axl</italic> relative to respective PBS injection control 2 hr after injection. Red line indicates normalized control mRNA levels. Error bars indicate mean ± SEM, unpaired t-test, n=4-8 mice; ***p&lt;0.001. ns, nonsignificant. (<bold>F</bold>) Quantification of corrected total fluorescence for Axl immunostaining in a 1 mm square containing the injection site. n=6-10 mice; Error bars indicate mean ± SEM, one-way ANOVA with multiple comparisons, *p&lt;0.05. (<bold>G</bold>) Schematic of injection and collection protocol. (<bold>H</bold>) Immunostaining for Axl (red) in naive back skin injected with PBS or IFNB. Arrows indicate Axl<sup>+</sup> cells. * indicates injection site. (<bold>I</bold>) Immunostaining for Axl (red) in wound beds 24 hr after injury in wild-type (WT) or <italic>TLR3</italic> knockout (KO) mice. Arrows indicate Axl<sup>+</sup> cells. * indicates scab. Scale bars = 500 µm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-86269-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Poly(I:C) injection does not elicit Axl expression in <italic>TLR3</italic> knockout (KO) model.</title><p>(<bold>A</bold>) mRNA expression of cytokine genes relative to respective PBS injection. Red line indicates normalized control mRNA levels. Error bars indicate mean ± SEM, n=4-6 mice. (<bold>B</bold>) Immunostaining for Axl (red) in naive back skin of <italic>TLR3</italic> KO mice injected with PBS or Poly(I:C). Arrows indicate Axl<sup>+</sup> cells. * indicates injection site. Scale bar = 500 µm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-86269-fig4-figsupp1-v1.tif"/></fig></fig-group><p>Since <italic>Ifnb</italic> was elevated by TLR3 signaling in naive skin, we determined whether injecting recombinant IFN-β intradermally into naive mouse back skin was sufficient to induce Axl protein expression (<xref ref-type="fig" rid="fig4">Figure 4G</xref>). Two hours after injection, Axl protein was detected by immunostaining in skin injected with IFN-β but not control skin (<xref ref-type="fig" rid="fig4">Figure 4H and F</xref>). Next, to determine if TLR3 activation was necessary for Axl expression in skin wounds, we analyzed Axl expression in wound beds of <italic>TLR3</italic> KO mice. In contrast to our previous results in naive skin, Axl protein expression was stimulated in <italic>TLR3</italic> KO wound beds similar to WT mice (<xref ref-type="fig" rid="fig4">Figure 4I</xref>). Thus, these data suggest that while TLR3 is sufficient to drive Axl expression in naive skin, additional mechanisms drive Axl upregulation within skin wounds in its absence.</p></sec><sec id="s2-5"><title>Axl is required for skin wound healing</title><p>Based on our data showing upregulation of Axl mRNA and protein expression in wound beds, even in the absence of TLR3, we hypothesized that Axl may play a role in wound healing. To examine whether Axl signaling was required for wound repair, we intraperitoneally injected mice 3 hr prior to injury with either a control IgG Ab or anti-Axl function blocking Ab, which binds to Axl’s extracellular domain and blocks Axl-mediated viral infection (<xref ref-type="bibr" rid="bib35">Retallack et al., 2016</xref>), and has been shown to inhibit Axl activity in vitro (<xref ref-type="bibr" rid="bib3">Bauer et al., 2012</xref>; <xref ref-type="fig" rid="fig5">Figure 5A</xref>). Since Axl activity upregulates <italic>Axl</italic> mRNA expression in a positive feedback loop (<xref ref-type="bibr" rid="bib6">Brand et al., 2014</xref>), we analyzed <italic>Axl</italic> mRNA expression in wounds of Ab-treated mice. While we saw a nonsignificant downregulation of <italic>Axl</italic> mRNA at 1 day (D) post injury, <italic>Axl</italic> mRNA was significantly downregulated in skin wounds treated with anti-Axl Ab on day 5 compared to control IgG Ab injected wounds (<xref ref-type="fig" rid="fig5">Figure 5B</xref>), indicating that the anti-Axl Ab treatment reduced Axl signaling in skin wounds.</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Axl antibody (Ab) inhibition results in defects to wound repair and changes to inflammation.</title><p>(<bold>A</bold>) Schematic of experimental design. (<bold>B</bold>) <italic>Axl</italic> mRNA expression normalized to respective IgG Ab control. Error bars indicate mean ± SEM, one-way ANOVA with multiple comparisons, n=4 mice, *p&lt;0.05. (<bold>C</bold>) Representative flow cytometry gates used to analyze cells isolated from wounds 3 days after injection and injury. Live singlet CD45<sup>+</sup> cells were identified as macrophages, neutrophils, or dendritic cells via fluorescent antibody staining. (<bold>D</bold>) Top: Quantification of CD45<sup>+</sup> cells by cell type in anti-Axl Ab or IgG Ab-treated wound beds 3 days after injury. Error bars indicate mean ± SEM, one-way ANOVA with multiple comparisons, n=4 mice, ns, nonsignificant. Bottom: Quantification of Axl<sup>+</sup> cells by cell type in anti-Axl Ab or IgG Ab-treated wound beds 3 days after injury. Error bars indicate mean ± SEM, two-way ANOVA with multiple comparisons, n=4 mice, **p&lt;0.01. ns, nonsignificant. (<bold>E</bold>) Left: Hematoxylin and eosin (H&amp;E) staining of wound beds 5 days after antibody injection and injury. Center: Immunostaining for aSMA (green) in wound beds 5 days after antibody injection and injury. Right: Immunostaining for CD31 (green) in wound beds 5 days after antibody injection and injury. * indicates scab. (<bold>F</bold>) Top: Quantification of aSMA corrected total fluorescence. Error bars indicate mean ± SEM, unpaired t-test, n=10 mice, *p&lt;0.05. Bottom: Quantification of CD31<sup>+</sup> pixels in wound bed. Error bars indicate mean ± SEM, unpaired t-test, **p&lt;0.01. Scale bars = 500 µm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-86269-fig5-v1.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Analysis of anti-Axl antibody (Ab) and IgG control-treated wound beds.</title><p>(<bold>A</bold>) Left: Immunostaining for TUNEL (green) in wound beds injected with anti-Axl Ab or IgG Ab control 1 day after injury. Arrows indicate TUNEL<sup>+</sup> cells. * indicates scab. Scale bars = 500 µm. Right: Quantification of TUNEL<sup>+</sup> cells per 10<sup>6</sup> square pixels in 1-day wounds. Error bars indicate mean ± SEM. ns, nonsignificant. (<bold>B</bold>) Quantification of cleaved caspase 3<sup>+</sup> cells per 10<sup>6</sup> square pixels in 3- and 5-day wounds. Error bars indicate mean ± SEM. ns, nonsignificant. (<bold>C</bold>) mRNA expression of genes involved in TAM receptor signaling and cytokines relative to IgG Ab control 1 and 5 days after injury. Red line indicates normalized control mRNA levels for respective IgG control. Error bars indicate mean ± SEM, one-way ANOVA with multiple comparisons, *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001. (<bold>D</bold>) Representative fluorescence-activated single-cell sorting (FACS) dot plots of gating strategy to identify single cells, CD45<sup>+</sup> immune cells, Axl<sup>+</sup> cells, and immune cell populations. (<bold>E</bold>) Left: Immunostaining for ITGA6 (green) in wound beds 5 days after antibody injection and injury. Right: Quantification of % re-epithelialization for 5-day wound beds. Error bars indicate mean ± SEM, ns, nonsignificant.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-86269-fig5-figsupp1-v1.tif"/></fig></fig-group><p>Next, we examined the effect of Axl inhibition on apoptotic cell clearance in skin wounds. TUNEL<sup>+</sup> cells were present but rare in both anti-Axl Ab and IgG Ab-treated 1-day wounds (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A</xref>). Additional staining in sections from wounds 3 and 5 days after injury also showed no significant difference in cleaved (active) caspase 3<sup>+</sup> cells in anti-Axl Ab and IgG Ab-treated wounds (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1B</xref>). Further, we detected no significant changes to gene expression of selected members of the efferocytosis signaling pathway or common inflammatory cytokines 1 day after injury, indicating no major inflammatory defects (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1C</xref>). Thus, additional efferocytosis mechanisms, potentially including other members of the TAM family, likely clear apoptotic cells in early skin wounds despite Axl inhibition.</p><p>To characterize the impact of Axl inhibition on inflammation at 3 days after injury, we used flow cytometry to quantify the immune cells present in the wound bed (<xref ref-type="fig" rid="fig5">Figure 5C–D</xref> and <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1D</xref>). Interestingly, no significant change was observed in the proportion of dendritic cells, neutrophils, or macrophages that were present in IgG or anti-Axl Ab-treated wound beds. However, the proportion of cell types expressing Axl was altered, with more Axl<sup>+</sup> macrophages and fewer Axl<sup>+</sup> DCs present in the anti-Axl Ab-treated group compared to the IgG Ab control.</p><p>Despite the relatively normal inflammatory cell numbers at day 3 after injury, wounds treated with anti-Axl Ab exhibited observable healing defects at 5 days post injury compared to wounds treated with control IgG Ab, including a qualitative lack of granulation tissue visible with hematoxylin and eosin (H&amp;E) staining (<xref ref-type="fig" rid="fig5">Figure 5E</xref>). We also observed that upon Axl inhibition, fibroblast repopulation was significantly reduced (<xref ref-type="fig" rid="fig5">Figure 5E–F</xref>). Revascularization was also defective; Axl inhibition significantly reduced the CD31<sup>+</sup> area of wound beds (<xref ref-type="fig" rid="fig5">Figure 5E–F</xref>). However, we observed no significant difference in the percentage of wound closure by keratinocytes as indicated by ITGA6 staining between the two treatments (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1E</xref>).</p><p>We observed significant changes in gene expression at 5 days after injury in wounds lacking Axl activity, including a significant downregulation of <italic>Arg1, Tgfb</italic>, and <italic>Il1a</italic>, and significant upregulation of <italic>Ifnb, Socs1</italic>, and <italic>Socs3</italic> upon Axl inhibition (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1C</xref>). Taken together, these changes suggest that Axl inhibition impairs proper healing, resulting in significant defects to revascularization and fibroblast repopulation.</p></sec><sec id="s2-6"><title>Timd4 function is required for normal skin repair</title><p>To further examine the role of efferocytosis receptors in skin wound repair, we abrogated the function of a member of the TIM family of receptors, Timd4. Intraperitoneal injection of a function blocking anti-Timd4 Ab effectively blocks efferocytosis in an atherosclerosis mouse model (<xref ref-type="bibr" rid="bib13">Foks et al., 2016</xref>). Strikingly, we found that wounds of mice treated with anti-Timd4 Ab displayed significantly more TUNEL<sup>+</sup> apoptotic cells in 1- and 5-day wound beds compared to wounds of IgG Ab-treated mice (<xref ref-type="fig" rid="fig6">Figure 6A–B</xref>). Similarly, we observed an increase in cleaved caspase 3<sup>+</sup> cells in wounds of anti-Timd4 Ab-treated mice (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1A</xref>). While this does not preclude the possibility of an increase in apoptosis upon Ab treatment, it is consistent with a defect to efferocytosis.</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Timd4 function is required for efferocytosis during skin repair.</title><p>(<bold>A</bold>) Immunostaining for TUNEL (green) in wound beds injected with anti-Timd4 antibody (Ab) or IgG Ab control 1, 3, or 5 days after injury. Arrows indicate TUNEL<sup>+</sup> cells. * indicates scab. (<bold>B</bold>) Quantification of TUNEL<sup>+</sup> cells per mm<sup>2</sup> in the wound bed. Error bars indicate mean ± SEM, one-way ANOVA, n=3-7 mice; *p&lt;0.05, ns, nonsignificant. (<bold>C</bold>) Hematoxylin and eosin (H&amp;E) staining of wound beds 5 days after antibody injection and injury. (<bold>D</bold>) Immunostaining for aSMA (red) in wound beds 5 days after antibody injection and injury. (<bold>E</bold>) Immunostaining for CD31 (green) in wound beds 5 days after antibody injection and injury. (<bold>F</bold>) Left: Quantification of aSMA corrected total fluorescence. Error bars indicate mean ± SEM. ns, nonsignificant. Right: Quantification of CD31<sup>+</sup> pixels in wound bed. Error bars indicate mean ± SEM, unpaired t-test, n=6-9 mice; *p&lt;0.05. (<bold>G</bold>) mRNA expression of genes relative to respective IgG Ab control. Red line indicates normalized control mRNA levels. Error bars indicate mean ± SEM, n=4-6 mice; unpaired t-test *p&lt;0.01, **p&lt;0.01. Scale bars = 500 µm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-86269-fig6-v1.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>Re-epithelialization is not significantly altered in anti-Axl antibody and IgG control-treated wound beds.</title><p>(<bold>A</bold>) Immunostaining for cleaved caspase 3 (red) in wound beds 5 days after antibody injection and injury. (<bold>B</bold>) Immunostaining for ITGA6 (green) in wound beds 5 days after antibody injection and injury. (<bold>C</bold>) Quantification of % re-epithelialization for 5-day wound beds. Error bars indicate mean ± SEM. n=3 mice; * indicates scab. Scale bars = 500 µm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-86269-fig6-figsupp1-v1.tif"/></fig></fig-group><p>Inhibition of Timd4 resulted in qualitative defects in granulation tissue in H&amp;E-stained sections of 5-day wounds (<xref ref-type="fig" rid="fig6">Figure 6C</xref>). Immunostaining of wound sections with Abs against aSMA (<xref ref-type="fig" rid="fig6">Figure 6D and F</xref>) and ITGA6 (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1B–C</xref>) did not indicate significant changes to either fibroblast repopulation or re-epithelialization, respectively. However, staining for CD31 (<xref ref-type="fig" rid="fig6">Figure 6E–F</xref>) revealed a significant defect to revascularization in wounds of anti-Timd4 Ab mice compared to wounds of IgG Ab-treated mice, which indicates a defect to proper healing in the proliferative phase of wound repair.</p><p>Next, we examined mRNA expression profiles of inflammatory and efferocytosis signaling pathways in IgG Ab and anti-Timd4 Ab-treated wound beds (<xref ref-type="fig" rid="fig6">Figure 6G</xref>). The inflammatory cytokines <italic>Ifng</italic> and <italic>Ifnb</italic> were significantly upregulated at day 1 or 3, respectively, in Timd4-inhibited wounds compared to control wounds, suggesting altered inflammatory signaling. Interestingly, at day 1 and/or day 3, <italic>Socs1</italic> and <italic>Socs3</italic> were also significantly upregulated, similar to the gene expression pattern observed after Axl inhibition (<xref ref-type="fig" rid="fig5">Figure 5I</xref>). Taken together, these results indicate that Timd4 activity is required for reducing apoptotic cells, inflammation gene expression, and revascularization after injury.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Here, we provide an atlas for the dynamic changes that occur in the early inflammatory stage of wound repair in the skin at the single-cell level. We found that apoptotic and efferocytosis pathways were upregulated in distinct cell types in mouse wounds and in diabetic foot wounds of human patients. Using functional inhibition studies in mouse wounds, our data show that efferocytosis receptors, Axl and Timd4, have differential effects on efferocytosis and wound repair.</p><p>We found that apoptotic genes were upregulated in most of the cell types present in early wounds, which likely allows the dynamic shifts in transcriptional profiles of inflammatory cells we observed in the first few days of tissue repair. Apoptotic cells are required for tail regeneration of <italic>Xenopus laevis</italic> (<xref ref-type="bibr" rid="bib44">Tseng et al., 2007</xref>) and tissue regeneration of planaria (<xref ref-type="bibr" rid="bib19">Hwang et al., 2004</xref>) and have been widely implicated in early wound repair (<xref ref-type="bibr" rid="bib15">Greenhalgh, 1998</xref>; <xref ref-type="bibr" rid="bib2">Arya et al., 2014</xref>). Mechanistically, apoptotic cells can release signaling factors including Wnts and PGE2 to promote proliferation of tissue resident cells and tissue repair in multiple species (<xref ref-type="bibr" rid="bib8">Codispoti et al., 2019</xref>; <xref ref-type="bibr" rid="bib26">Li et al., 2010</xref>; <xref ref-type="bibr" rid="bib14">Fuchs et al., 2013</xref>). Detection of apoptotic cells has also been linked to inflammation and context-dependent integration of IL-4 signaling to activate an anti-inflammatory and tissue repair gene program (<xref ref-type="bibr" rid="bib4">Bosurgi et al., 2017a</xref>).</p><p>Exposure of PtdSer on the outer leaflet of apoptotic cell membranes acts as a sensor for engulfment in evolutionarily conserved mechanisms (<xref ref-type="bibr" rid="bib39">Rothlin and Ghosh, 2020</xref>). Our data suggest that in skin wounds, apoptotic cells are rapidly detected and removed via efferocytosis, which is consistent with the large number of phagocytic neutrophils and macrophages in early wounds. We also found that mRNAs encoding efferocytosis receptors and signaling pathways are upregulated in the early skin wound beds and in diabetic foot wounds, and confirmed protein upregulation of the efferocytosis receptors Axl and Timd4 in murine wounds. Interestingly, efferocytosis receptors were upregulated in professional phagocytes as well as in fibroblasts, which also increased expression of a large number of efferocytosis ligands in both mouse wounds and diabetic foot ulcers (<xref ref-type="fig" rid="fig2">Figures 2</xref> and <xref ref-type="fig" rid="fig3">3</xref>). These data resonate with recent data suggesting that fibroblasts can engulf apoptotic endothelial cells to alter their contractility, migration, and ECM production (<xref ref-type="bibr" rid="bib37">Romana-Souza et al., 2021</xref>), and may indicate a direct role for fibroblasts in modulating the inflammatory milieu of early wounds through detection of apoptotic cells.</p><p>Growing evidence suggests that distinct efferocytosis receptors elicit cell- and tissue-specific responses. Axl and Mer exhibit differential ligand specificity and shedding upon activation (<xref ref-type="bibr" rid="bib52">Zagórska et al., 2014</xref>). Furthermore, <italic>Axl</italic> null bone marrow-derived macrophages are unable to perform efferocytosis with TLR3 activation in vitro, which suggests that Axl plays a central role in efferocytosis in inflammatory environments (<xref ref-type="bibr" rid="bib5">Bosurgi et al., 2017b</xref>). Here, we show that in early murine skin wounds, Axl inhibition did not impact efferocytosis in a detectable manner, but rather Axl expression shifted from dendritic cells to macrophages, suggesting possible compensatory mechanisms via other efferocytosis receptors. Furthermore, we did not detect differences in <italic>Axl</italic> expression in <italic>TLR3</italic> null and control wounds, further suggesting the inflammatory wound environment in vivo displays activation of <italic>Axl</italic> receptor expression independent of TLR3. Axl may function in skin wounds by interacting with other tyrosine kinase receptors, which has been shown for EGFR, MET, and PDGFR (<xref ref-type="bibr" rid="bib31">Meyer et al., 2013</xref>). Interestingly, Axl/Gas6 signaling can also regulate tumorigenesis to support tumor cell survival (<xref ref-type="bibr" rid="bib29">Linger et al., 2008</xref>), migration (<xref ref-type="bibr" rid="bib48">Wilson et al., 2014</xref>), and angiogenesis (<xref ref-type="bibr" rid="bib25">Li et al., 2009</xref>; <xref ref-type="bibr" rid="bib53">Zhu et al., 2019</xref>). Future work exploring Axl’s function in a cell type-dependent manner, including possibly directly activating angiogenesis in skin wounds, will decipher these possibilities.</p><p>Our data also implicate an important role for resident macrophages in regulating early wound repair mechanisms. In particular, we identified the expression of several efferocytosis receptors and ligands on Lyve1<sup>+</sup> resident macrophages including Timd4. Timd4 is expressed on tissue resident macrophages in multiple tissues including in the peritoneal and resident cardiac macrophages. In the heart, Lyve1<sup>+</sup> resident macrophages act in a cardioprotective manner during myocardial infarction (<xref ref-type="bibr" rid="bib9">Dick et al., 2019</xref>) and are immunoregulatory and promote engraftment of cardiac allografts (<xref ref-type="bibr" rid="bib43">Thornley et al., 2014</xref>). Interestingly, similar to our data, Timd4 promotes efferocytosis in the heart. During cardiac infarction, Timd4 is also required for T cell responses and support of regulatory T cells (Tregs) (<xref ref-type="bibr" rid="bib13">Foks et al., 2016</xref>). In the skin, Timd4 is essential for allograft survival (<xref ref-type="bibr" rid="bib50">Yeung et al., 2013</xref>), which has been proposed to act through DCs to support Tregs. Indeed, Timd4 is expressed in DCs in later stages of wound repair (<xref ref-type="bibr" rid="bib17">Haensel et al., 2020</xref>). Our future studies will test the role of Timd4 on DCs and resident macrophages, T cell immunity, and how they impact wound repair phenotypes noted with Timd4 inhibition.</p><p>In summary, our data implicate apoptosis recognition receptors as an important regulator of skin wound healing. We find that early murine wound beds and human diabetic foot wounds significantly upregulate apoptotic genes and receptors that recognize apoptotic cells and that inhibition of multiple apoptotic receptors impairs wound repair. Given the importance of apoptosis in wound repair and the expression of distinct apoptotic receptors in different cells, skin wound healing is an excellent model to decipher the mechanisms by which distinct cells recognize and respond to interactions with apoptotic cells. Given further research into the healing phenotypes of efferocytosis-inhibited wounds, it may be that targeting these mechanisms may reveal therapeutic avenues that promote healing in chronic, non-healing wounds, particularly in diabetic patients.</p></sec><sec id="s4" sec-type="methods"><title>Methods</title><sec id="s4-1"><title>Animals</title><p>WT C57BL/6J mice (Strain #:000664), B6;129S1-Tlr3tm1Flv/J (<italic>TLR3</italic> KO) mice (Strain #:005217), Lyz2tm1(cre/ERT2)Grtn/J (<italic>Lyz2</italic>CreER) mice (Strain #:031674), and B6.129(Cg)-Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/J (mTmG) mice (Strain #:007676) were purchased from The Jackson Laboratories. <italic>Pdgfra</italic>CreER mice were developed in the laboratory of B. Hogan (Duke University, Durham, NC, USA). Mice were maintained through routine breeding in an Association for Assessment and Accreditation of Laboratory Animal Care (AALAC)-accredited animal facility at Yale University (Protocol # 11248). Animals were maintained on a standard chow diet ad libitum (Harlan Laboratories, 2018S) in 12 hr light/dark cycling. Up to five injured mice were housed per cage. All experimental procedures were approved and in accordance with the Institutional Animal Care and Use Committee. For experiments using intraperitoneal (i.p.) tamoxifen administration, 100 μL of 30 mg/mL tamoxifen (Sigma-Aldrich) in sesame oil was injected daily for 3 days prior to experiments.</p></sec><sec id="s4-2"><title>Human subjects</title><p>Diabetic and non-diabetic adults with chronic foot ulcers that were undergoing skin wound debridement were consented to donate discarded tissue for this study (IRB approval # 1609018360). The diabetic foot ulcer specimens for scRNA-seq were obtained from five individuals diagnosed with Type 2 diabetes. The non-diabetic foot wound specimens for scRNA-seq were obtained from four individuals, two of whom provided multiple samples. The diabetic foot ulcer specimens for immunofluorescence staining were obtained from five individuals diagnosed with Type 2 diabetes and one individual diagnosed with Type 1 diabetes. The non-diabetic foot wound specimens for immunofluorescence staining were obtained from two individuals. Demographic information listed in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref> .</p></sec><sec id="s4-3"><title>Wounding</title><p>Seven- to 9-week-old male mice were wounded during the telogen phase of hair cycling. Mice were anesthetized using isoflurane and six full-thickness wounds, at least 4 mm apart, were made on shaved back skin using a 4 mm biopsy punch (Millitex). Animals were sacrificed at noted intervals after injury and wound beds were processed for subsequent analysis.</p></sec><sec id="s4-4"><title>Single-cell digestion of mouse wounds</title><p>Wound beds were digested for scRNA-seq analysis in a buffer of Roswell Park Memorial Institute (RPMI) medium with glutamine (Gibco), Liberase Thermolysin Medium (TM) (Roche), DNase, <italic>N</italic>-2-hydroxyethylpiperazine-<italic>N</italic>-2-ethane sulfonic acid (Gibco), sodium pyruvate (Gibco), non-essential amino acids (Gibco), and antibiotic-antimycotic (100X) (Gibco). Blood cells were removed with ammonium-chloride-potassium (ACK) lysing buffer (Gibco). Cells were resuspended in Dulbecco’s Modified Eagle’s Medium (DMEM) (ATCC) with 0.1% bovine serum albumin (BSA) for analysis.</p></sec><sec id="s4-5"><title>Human skin collection and processing for scRNA-seq</title><p>Skin wound specimens were collected at the clinical setting in PBS with antibiotic-antimycotic (100X) (Gibco), and transported to the lab on ice for processing. All specimens were processed within 3 hr of collection. The specimen was cleaned by immersion with 10% betadine, 70% ethanol, and PBS. Excess blood and subcutaneous fat were removed, and skin was mechanically minced before being digested in an enzyme cocktail consisting of dispase (Stemcell Technologies), collagenase I (Worthington), and collagenase II (Worthington) in 0.25% trypsin-EDTA (Gibco). Blood cells were removed with ACK lysing buffer (Gibco). Cells were resuspended in DMEM (ATCC) with 0.1% BSA for analysis.</p></sec><sec id="s4-6"><title>Human skin collection and processing for staining</title><p>Human tissue sections were kept for at least 24 hr in 10% neutral buffered formalin and dehydrated in alcohol diluted in 0.9% NaCl/dH<sub>2</sub>O; the sequence being 30% EtOH, 50% EtOH, 70%EtOH. Specimens remained in 70% EtOH overnight. The following day, sections were dehydrated further in 85%, 95%, and 100% ethanol diluted in distilled water before being preserved in 50% EtOH/ 50% xylene and then 100% xylene. Tissue sections were allowed to soak in paraffin for at least 1 hr and then embedded in disposable molds with melted paraffin wax. Five µm tissue sections were obtained and adhered to charged slides for histological analysis.</p></sec><sec id="s4-7"><title>Single-cell data of mouse samples</title><p>scRNA-seq data from 24 hr and 48 hr mouse wound beds were processed using the standard cellranger pipeline (10X Genomics). Downstream analysis was performed using the Scanpy package in Python (<xref ref-type="bibr" rid="bib49">Wolf et al., 2018</xref>). Cells were filtered for quality control to avoid doublets and dead cells. Dimensionality reduction and downstream data visualization were completed using the Scanpy implementation of UMAP (<xref ref-type="bibr" rid="bib30">McInnes et al., 2020</xref>) and the ShinyCell package in R (<xref ref-type="bibr" rid="bib32">Ouyang et al., 2021</xref>), respectively. Data is presented as scaled log-normalized mRNA counts (i.e., expression).</p><p>We adapted the cell-type annotation pipeline from <xref ref-type="bibr" rid="bib22">Kumar et al., 2018</xref>, to label our sequencing data by broad cell type, as was done in <xref ref-type="bibr" rid="bib47">Wasko et al., 2022</xref>. Differentially expressed genes (DEGs) across timepoints were calculated using the rank_genes_groups function from the Scanpy module in Python with default parameters. We then performed enrichment analysis on the top (logfoldchanges &gt;1.5) DEGs for each group using g:Profiler (<xref ref-type="bibr" rid="bib34">Raudvere et al., 2019</xref>), with the GO knowledgebase as the reference database.</p></sec><sec id="s4-8"><title>Neutrophil injection</title><p>Cells were collected from WT bone marrow as previously described (<xref ref-type="bibr" rid="bib36">Rios et al., 2017</xref>). Neutrophils were isolated using MACS Ly6G beads (Miltenyi Biotech 130-120-337). Neutrophils were stained with CFSE cell labeling kit (Abcam ab113853) for 15 min. Stained neutrophils were incubated overnight in RPMI medium to induce apoptosis. 10,000 neutrophils in 50 µL PBS or 50 µL PBS control were injected under the scab and into the wound bed of 1-, 3-, or 5-day wounded mice. Injected mice were sacrificed after 1 hr.</p></sec><sec id="s4-9"><title>Single-cell data of human samples</title><p>Human scRNA-seq data from human samples were generated from 10X Genomics 3’-end single-cell gene expression V2. Analysis was performed in Scanpy (<xref ref-type="bibr" rid="bib49">Wolf et al., 2018</xref>). Cells were filtered for doublets and dead cells for downstream analysis. Batch correction was performed to integrate cells across samples using Scanorama (<xref ref-type="bibr" rid="bib18">Hie et al., 2019</xref>). Gene expression was scaled, log-transformed, and normalized. Dimensionality reduction was done using PCA and UMAP in Scanpy (<xref ref-type="bibr" rid="bib30">McInnes et al., 2020</xref>). DEGs were calculated using Wilcoxon rank_genes_groups function from Scanpy. Cell-cell communication analysis and data visualization of circos plot were performed using CellChat (<xref ref-type="bibr" rid="bib20">Jin et al., 2021</xref>). CellChat is superior to similar methods because its algorithm accounts for the roles of both signaling cofactors and protein-protein signaling in its predictions of ligand-receptor interaction (<xref ref-type="bibr" rid="bib7">Bridges and Miller-Jensen, 2022</xref>). CellChat is available as an open-source software package in R.</p></sec><sec id="s4-10"><title>Staining and imaging</title><p>Mouse skin and wound beds were embedded in optimum cutting temperature compound (VWR) and wound beds were sectioned through their entirety to identify the center. 7 µm or 14 µm cryosections were processed as previously described (<xref ref-type="bibr" rid="bib41">Shook et al., 2016</xref>) and stained with Abs listed below or H&amp;E.</p><p>Human tissue slides were warmed in the oven at 60°C for an hour before being deparaffinized and rehydrated in ethanol diluted in water. Antigen retrieval was performed at 80°C for an hour and after slides had cooled, nonspecific blocking was performed, the primary Ab was added, and the slides rested overnight at 4°C. The next day, slides were warmed to room temperature, washed, and the secondary Ab was allowed to penetrate for 1 hr at room temperature. Prolong Gold plus DAPI was added to each tissue section and cover slides were added. Slides rested at 4°C for at least 1 day before imaging.</p><p>Composite images were acquired using the tiles module on a Zeiss AxioImager M1 (Zeiss) equipped with an Orca camera (Hamamatsu).</p></sec><sec id="s4-11"><title>Quantitative real-time PCR</title><p>Whole wound bed samples were digested using TRIzol LS (Invitrogen). RNA was extracted from the aqueous phase using the RNeasy Plus Mini Kit (QIAGEN). cDNA was generated using equal amounts of total RNA with the Superscript III First Strand Synthesis Kit (Invitrogen) per manufacturer’s instructions. All quantitative real-time PCR was performed using SYBR green on a LightCycler 480 (Roche). Primers for specific genes are listed below. Results were normalized to β-actin as previously described.</p></sec><sec id="s4-12"><title>Injections</title><p>Seven- to 9-week-old male mice were injected intradermally with 10 µL PBS, 50 µg/mL Poly(I:C) (Invivogen), or 5 µg/mL IFNB (R&amp;D) with 0.5% BSA. The injection site was isolated using a 6 mm biopsy punch 2 hr after injection and processed for staining.</p><p>To inhibit signaling pathways in vivo, 7- to 9-week-old male mice were injected intraperitoneally with 25 µg/100 µL anti-Axl Ab (R&amp;D), 200 µg/100 µL anti-Timd4 (BioXCell), or equivalent unit IgG control (R&amp;D) in PBS 3 hr before wounding.</p></sec><sec id="s4-13"><title>Flow cytometry</title><p>Mouse wound beds were dissected and digested into single cells using Liberase TM (Roche) and cells were suspended in fluorescence-activated single-cell sorting (FACS) staining buffer (0.05% BSA in DMEM). Digested tissue was filtered with a 70 μm and 40 μm cell strainer prior to centrifugation. Cell suspensions were stained with Abs for 30 min on ice. Dendritic cells were defined as CD11b<sup>+</sup> Cd11c<sup>+</sup> cells; macrophages were defined as CD11b<sup>+</sup> CD11c<sup>-</sup> CD64<sup>+</sup> Ly6G<sup>-</sup> cells; neutrophils were defined as CD11b<sup>+</sup> CD11c<sup>-</sup> CD64<sup>-</sup> Ly6G<sup>+</sup> cells. To exclude dead cells, Sytox Blue (Invitrogen, 1:1000) was added immediately before analysis or sorting using a FACS Aria III with FACS DiVA software (BD Biosciences). Flow cytometry analysis was performed using FlowJo Software (FlowJo).</p></sec><sec id="s4-14"><title>Image quantification</title><p>Histological quantification for each wound bed was conducted on multiple central sections for each wound bed when available. The percentage of the wound bed covered by ITGA6 staining (re-epithelialization) and CTF for Axl (in a 1 mm square around the injection site) or aSMA (in the wound bed) were calculated using ImageJ software (National Institutes of Health, Bethesda, MD, USA) as described previously (<xref ref-type="bibr" rid="bib40">Schmidt and Horsley, 2013</xref>; <xref ref-type="bibr" rid="bib42">Shook et al., 2018</xref>). Revascularization (CD31<sup>+</sup>) was calculated using Adobe Photoshop to measure the total pixels positive for Ab staining divided by the total number of pixels in wound beds. Cell death was quantified using the RETINA Analysis Toolkit in FIJI (<ext-link ext-link-type="uri" xlink:href="https://imagej.net/plugins/retina-analysis-toolkit">https://imagej.net/plugins/retina-analysis-toolkit</ext-link>).</p></sec><sec id="s4-15"><title>Statistics</title><p>To determine significance between two groups, comparisons were made using Student’s t-test. Analyses across multiple groups were made using a one- or two-way ANOVA with Bonferroni’s post hoc using GraphPad Prism for Mac (GraphPad Software, La Jolla, CA, USA) with significance set at p&lt;0.05. Sample sizes were determined using power analysis and taking into consideration our experience with the wounding model.</p></sec><sec id="s4-16"><title>Antibodies</title><list list-type="simple"><list-item><p>TUNEL kit: Click-iT Plus TUNEL Assay for In Situ Apoptosis Detection, Alexa Fluor 488 dye Thermo Fisher C10617</p></list-item><list-item><p>Axl: Bioss Cat# bs-5180R, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_11110961">AB_11110961</ext-link></p></list-item><list-item><p>Axl: R&amp;D Systems Cat# AF154, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_354852">AB_354852</ext-link></p></list-item><list-item><p>CD31: BD Biosciences Cat# 550274, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_393571">AB_393571</ext-link></p></list-item><list-item><p>CD31: Millipore Cat# MAB1398Z, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_94207">AB_94207</ext-link></p></list-item><list-item><p>CD68: Abcam Cat# ab237968</p></list-item><list-item><p>CD11c: Abcam Cat# ab33483, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_726084">AB_726084</ext-link></p></list-item><list-item><p>Cleaved Caspase 3: Cell Signaling Technology Cat# 9661, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2341188">AB_2341188</ext-link></p></list-item><list-item><p>Gas6: Thermo Fisher Scientific Cat# PA5-103199, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2852567">AB_2852567</ext-link></p></list-item><list-item><p>Gas6: Bioss Cat# bs-7549R-A488</p></list-item><list-item><p>GFP: Abcam Cat# ab13970, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_300798">AB_300798</ext-link></p></list-item><list-item><p>IgG: R&amp;D Systems Cat# AB-108-C, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_354267">AB_354267</ext-link></p></list-item><list-item><p>IgG: Bio X Cell Cat# BE0290, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2687813">AB_2687813</ext-link></p></list-item><list-item><p>ITGA6: R&amp;D Systems Cat# MAB13501, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2128311">AB_2128311</ext-link></p></list-item><list-item><p>Lyve1: Abcam Cat# ab14917, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_301509">AB_301509</ext-link></p></list-item><list-item><p>Timd4: Thermo Fisher Scientific Cat# PA5-116045, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2900679">AB_2900679</ext-link></p></list-item><list-item><p>Timd4: Bio X Cell Cat# BE0171, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2687695">AB_2687695</ext-link></p></list-item><list-item><p>aSMA: Abcam Cat# ab5694, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2223021">AB_2223021</ext-link></p></list-item></list></sec><sec id="s4-17"><title>FACS antibodies</title><list list-type="simple"><list-item><p>Axl: BD Biosciences Cat# 748032, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2872493">AB_2872493</ext-link> - 1:200</p></list-item><list-item><p>Ly6G: BioLegend Cat# 127654, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2616999">AB_2616999</ext-link> - 1:400</p></list-item><list-item><p>CD206: BioLegend Cat# 141710, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10900445">AB_10900445</ext-link> - 1:250</p></list-item><list-item><p>CD11c: BioLegend Cat# 117318, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_493568">AB_493568</ext-link> - 1:500</p></list-item><list-item><p>CD40: BioLegend Cat# 124618, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2075922">AB_2075922</ext-link> - 1:200</p></list-item><list-item><p>CD64: BioLegend Cat# 139304, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10612740">AB_10612740</ext-link> - 1:300</p></list-item><list-item><p>CD45: Thermo Fisher Scientific Cat# 47-0451-82, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_1548781">AB_1548781</ext-link> - 1:200</p></list-item><list-item><p>CD11b: BioLegend Cat# 101212, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_312795">AB_312795</ext-link> - 1:200</p></list-item><list-item><p>Sytox Blue: Invitrogen Cat# S34857</p></list-item></list></sec><sec id="s4-18"><title>Primers</title><list list-type="simple"><list-item><p>Arg1 F: <named-content content-type="sequence">CATTGGCTTGCGAGACGTAGAC</named-content></p></list-item><list-item><p>Arg1 R: <named-content content-type="sequence">GCTGAAGGTCTCTTCCATCACC</named-content></p></list-item><list-item><p>Axl F: <named-content content-type="sequence">CGAGAGGTGACCTTGGAAC</named-content></p></list-item><list-item><p>Axl R: <named-content content-type="sequence">AGATGGTGGAGTGGCTGTC</named-content></p></list-item><list-item><p>Β-actin F:<named-content content-type="sequence">ATCAAGATCATTGCTCCTCCTGAG</named-content></p></list-item><list-item><p>B-actin R: <named-content content-type="sequence">CTGCTTGCTGATCCACATCTG</named-content></p></list-item><list-item><p>C3 F: <named-content content-type="sequence">CCAGCTCCCCATTAGCTCTG</named-content></p></list-item><list-item><p>C3 R: <named-content content-type="sequence">GCACTTGCCTCTTTAGGAAGTC</named-content></p></list-item><list-item><p>C4b F: <named-content content-type="sequence">ACTTCAGCAGCTTAGTCAGGG</named-content></p></list-item><list-item><p>C4b R: <named-content content-type="sequence">GTCCTTTGTTTCAGGGGACAG</named-content></p></list-item><list-item><p>Cd47 F: <named-content content-type="sequence">TGCGGTTCAGCTCAACTACTG</named-content></p></list-item><list-item><p>Cd47 R: <named-content content-type="sequence">GCTTTGCGCCTCCACATTAC</named-content></p></list-item><list-item><p>Cd300lb F: <named-content content-type="sequence">TGCAGGGTCCTCATCCGAT</named-content></p></list-item><list-item><p>Cd300lb R: <named-content content-type="sequence">TGTCCGTGTCATTTTGCCTGA</named-content></p></list-item><list-item><p>C1qa F: <named-content content-type="sequence">ATGGAGACCTCTCAGGGATG</named-content></p></list-item><list-item><p>C1qa R: <named-content content-type="sequence">ATACCAGTCCGGATGCCAGC</named-content></p></list-item><list-item><p>Cr1l F: <named-content content-type="sequence">ATGGAGGTCTCTTCTCGGAGT</named-content></p></list-item><list-item><p>Cr1l R: <named-content content-type="sequence">GGCCGAAGGCTACAAGGAG</named-content></p></list-item><list-item><p>Gas6 F:<named-content content-type="sequence">ATGAAGATCGCGGTAGCTGG</named-content></p></list-item><list-item><p>Gas6 R: <named-content content-type="sequence">CCAACTCCTCATGCACCCAT</named-content></p></list-item><list-item><p>Gla F: <named-content content-type="sequence">TCTGTGAGCTTGCGCTTTGT</named-content></p></list-item><list-item><p>Gla R: <named-content content-type="sequence">GCAGTCAAGGTTGCACATGAAA</named-content></p></list-item><list-item><p>Ifna F: <named-content content-type="sequence">CTTCCACAGGATACTGTGTACCT</named-content></p></list-item><list-item><p>Ifna R: <named-content content-type="sequence">TTCTGCTCTGACCACCCTCCC</named-content></p></list-item><list-item><p>Ifnb F: <named-content content-type="sequence">ATGAGTGGTGGTTGCAGGC</named-content></p></list-item><list-item><p>Ifnb R: <named-content content-type="sequence">TGACCTTTCAAATGCAGTAGATTCA</named-content></p></list-item><list-item><p>Ifng F: <named-content content-type="sequence">CAGGCCATCAGCAACAACATAAGC</named-content></p></list-item><list-item><p>Ifng R: <named-content content-type="sequence">ACCCCGAATCAGCAGCGACTC</named-content></p></list-item><list-item><p>Il10 F: <named-content content-type="sequence">GCCCAGAAATCAAGGAGCATT</named-content></p></list-item><list-item><p>Il10 R: <named-content content-type="sequence">TGCTCCACTGCCTTGCTCTTA</named-content></p></list-item><list-item><p>Il17 F: <named-content content-type="sequence">GTCGAGAAGATGCTGGTGGGTGTG</named-content></p></list-item><list-item><p>Il17 R: <named-content content-type="sequence">ACGTGGGGGTTTCTTAGGGGTCAG</named-content></p></list-item><list-item><p>Il6 F: <named-content content-type="sequence">AGCCCACCAAGAACGATAGTC</named-content></p></list-item><list-item><p>Il6 R: <named-content content-type="sequence">TTGTGAAGTAGGGAAGGCCG</named-content></p></list-item><list-item><p>Il1a F: <named-content content-type="sequence">TTGGTTAAATGACCTGCAACA</named-content></p></list-item><list-item><p>Il1a R: <named-content content-type="sequence">GAGCGCTCACGAACAGTTG</named-content></p></list-item><list-item><p>Il1b F: <named-content content-type="sequence">CTCATTGTGGCTGTGGAGAAG</named-content></p></list-item><list-item><p>Il1b R: <named-content content-type="sequence">ACACTAGCAGGTCGTCATCAT</named-content></p></list-item><list-item><p>Itgam F: <named-content content-type="sequence">TTCCTGGTGCCAGAAGCTGAA</named-content></p></list-item><list-item><p>Itgam R: <named-content content-type="sequence">CCCGTTGGTCGAACTCAGGA</named-content></p></list-item><list-item><p>Itgav F: <named-content content-type="sequence">CCGTGGACTTCTTCGAGCC</named-content></p></list-item><list-item><p>Itgav R: <named-content content-type="sequence">CTGTTGAATCAAACTCAATGGGC</named-content></p></list-item><list-item><p>Itgax F: <named-content content-type="sequence">CCCACCACTTCCTCCTGTAAC</named-content></p></list-item><list-item><p>Itgax R: <named-content content-type="sequence">AGCAATTGGGTCACAGGTTC</named-content></p></list-item><list-item><p>Mertk F: <named-content content-type="sequence">GGCTTTTGGCGTGACCATG</named-content></p></list-item><list-item><p>Mertk R: <named-content content-type="sequence">AGTTCATCCAAGCAGTCCTC</named-content></p></list-item><list-item><p>Mfge8 F: <named-content content-type="sequence">AGATGCGGGTATCAGGTGTGA</named-content></p></list-item><list-item><p>Mfge8 R: <named-content content-type="sequence">GGGGCTCAGAACATCCGTG</named-content></p></list-item><list-item><p>Pros1 F: <named-content content-type="sequence">TGGCAAGGAGACAGGTGTCAGT</named-content></p></list-item><list-item><p>Pros1 R: <named-content content-type="sequence">GAGCAGTGGTAACTTCCAGGAG</named-content></p></list-item><list-item><p>Retnla F: <named-content content-type="sequence">CCAATCCAGCTAACTATCCCTCC</named-content></p></list-item><list-item><p>Retnla R: <named-content content-type="sequence">CCAGTCAACGAGTAAGCACAG</named-content></p></list-item><list-item><p>Sirpa F: <named-content content-type="sequence">CCACGGGGAAGGAACTGAAG</named-content></p></list-item><list-item><p>Sirpa R: <named-content content-type="sequence">ACGTATTCTCCTGCGAAACTGTA</named-content></p></list-item><list-item><p>Slc7a11 F: <named-content content-type="sequence">GGCACCGTCATCGGATCAG</named-content></p></list-item><list-item><p>Slc7a11 R: <named-content content-type="sequence">CTCCACAGGCAGACCAGAAAA</named-content></p></list-item><list-item><p>Socs1 F: <named-content content-type="sequence">CCGTGGGTCGCGAGAAC</named-content></p></list-item><list-item><p>Socs1 R: <named-content content-type="sequence">AACTCAGGTAGTCACGGAGTACCG</named-content></p></list-item><list-item><p>Socs3 F: <named-content content-type="sequence">TCCCATGCCGCTCACAG</named-content></p></list-item><list-item><p>Socs3 R: <named-content content-type="sequence">ACAGGACCAGTTCCAGGTAATTG</named-content></p></list-item><list-item><p>Tgfb F: <named-content content-type="sequence">ACTGTGGAAATCAACGGGATCA</named-content></p></list-item><list-item><p>Tgfb R: <named-content content-type="sequence">CTTCCAACCCAGGTCCTTCC</named-content></p></list-item><list-item><p>Timd4 F: <named-content content-type="sequence">AGCTTCTCCGTACAGATGGAA</named-content></p></list-item><list-item><p>Timd4 R: <named-content content-type="sequence">CCCACTGTCACCTCGATTGG</named-content></p></list-item><list-item><p>Tnfa F: <named-content content-type="sequence">TGTCTACTCCTCAGAGCCCC</named-content></p></list-item><list-item><p>Tnfa R: <named-content content-type="sequence">TGAGTCCTTGATGGTGGTGC</named-content></p></list-item><list-item><p>Tyro3 F: <named-content content-type="sequence">GAGGATGTCCTCATTCCAGAGC</named-content></p></list-item><list-item><p>Tyro3 R: <named-content content-type="sequence">CACTGCCACTTTCACGAAGGAG</named-content></p></list-item><list-item><p>Vegfa F: <named-content content-type="sequence">CGACACGGGAGACAATGGGATGAA</named-content></p></list-item><list-item><p>Vegfa R: <named-content content-type="sequence">AGGGGCGGGGTGCTTTGTAGACT</named-content></p></list-item></list></sec><sec id="s4-19"><title>Inclusion and diversity</title><p>One or more of the authors of this paper self-identifies as: (1) an underrepresented ethnic minority in their field of research or within their geographical location, (2) a gender minority in their field of research, and (3) a member of the LGBTQ+ community. While citing references scientifically relevant for this work, we also actively worked to promote gender balance in our reference list.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>Reviewing editor, eLife</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Validation, Investigation, Visualization, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Formal analysis, Visualization, Writing – original draft</p></fn><fn fn-type="con" id="con3"><p>Validation, Investigation</p></fn><fn fn-type="con" id="con4"><p>Validation, Investigation</p></fn><fn fn-type="con" id="con5"><p>Formal analysis, Investigation</p></fn><fn fn-type="con" id="con6"><p>Investigation</p></fn><fn fn-type="con" id="con7"><p>Validation, Investigation</p></fn><fn fn-type="con" id="con8"><p>Formal analysis, Investigation</p></fn><fn fn-type="con" id="con9"><p>Investigation</p></fn><fn fn-type="con" id="con10"><p>Investigation</p></fn><fn fn-type="con" id="con11"><p>Investigation</p></fn><fn fn-type="con" id="con12"><p>Supervision</p></fn><fn fn-type="con" id="con13"><p>Conceptualization, Funding acquisition, Visualization, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con14"><p>Conceptualization, Supervision, Funding acquisition, Visualization, Writing – original draft, Writing – review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Diabetic and non-diabetic adults with chronic foot ulcers that were undergoing skin wound debridement were consented to donate discarded tissue for this study (IRB approval # 1609018360).</p></fn><fn fn-type="other"><p>Mice were maintained through routine breeding in an Association for Assessment and Accreditation of Laboratory Animal Care (AALAC)-accredited animal facility at Yale University (Protocol # 11248). Animals were maintained on a standard chow diet ad libitum (Harlan Laboratories, 2018S) in 12-hour light/dark cycling. Up to five injured mice were housed per cage. All experimental procedures were approved and in accordance with the Institutional Animal Care and Use Committee.</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Demographics as reported in subjects’ medical records.</title></caption><media xlink:href="elife-86269-supp1-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-86269-mdarchecklist1-v1.pdf" mimetype="application" mime-subtype="pdf"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>Sequencing data have been deposited in GEO under accession codes GSE223660 and GSE245703. The code to reproduce analyses of mouse scRNA-seq are available at DOI: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.5281/zenodo.7562716">10.5281/zenodo.7562716</ext-link>.</p><p>The following datasets were generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Horsley</surname><given-names>V</given-names></name><name><surname>Phan</surname><given-names>Q</given-names></name><name><surname>Schaefer-Sandoval</surname><given-names>T</given-names></name><name><surname>King</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2023">2023</year><data-title>Single Cell Analysis of Gene expression profile as single cell level of chronic diabetic foot ulcers and chronic non-diabetic foot ulcer Foot Wounds</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE245703">GSE245703</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset2"><person-group person-group-type="author"><name><surname>Justynski</surname><given-names>O</given-names></name><name><surname>Bridges</surname><given-names>K</given-names></name><name><surname>Krause</surname><given-names>W</given-names></name><name><surname>Forni</surname><given-names>MF</given-names></name><name><surname>Phan</surname><given-names>Q</given-names></name><name><surname>Sandoval-Schaefer</surname><given-names>T</given-names></name><name><surname>Driskell</surname><given-names>R</given-names></name><name><surname>Miller-Jensen</surname><given-names>K</given-names></name><name><surname>Horsley</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2023">2023</year><data-title>Apoptosis recognition receptors regulate skin tissue repair in mice</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE223660">GSE223660</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>We would like to thank members of the Horsley and Miller-Jensen laboratory for their feedback and critical analysis of these data and manuscript. We would also like to thank the Yale Animal Resources Center (YARC) staff for animal husbandry and the Yale Science Building (YSB) Imaging core facility for confocal use. VH is funded by NIH-NIAMS R01s AR076938, AR0695505, AR075412. KM-J is funded by NIH U01-CA238728, R01-CA238728, and R01-GM123011.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alexopoulou</surname><given-names>L</given-names></name><name><surname>Holt</surname><given-names>AC</given-names></name><name><surname>Medzhitov</surname><given-names>R</given-names></name><name><surname>Flavell</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3</article-title><source>Nature</source><volume>413</volume><fpage>732</fpage><lpage>738</lpage><pub-id pub-id-type="doi">10.1038/35099560</pub-id><pub-id pub-id-type="pmid">11607032</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arya</surname><given-names>AK</given-names></name><name><surname>Tripathi</surname><given-names>R</given-names></name><name><surname>Kumar</surname><given-names>S</given-names></name><name><surname>Tripathi</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Recent advances on the association of apoptosis in chronic non healing diabetic wound</article-title><source>World Journal of Diabetes</source><volume>5</volume><fpage>756</fpage><lpage>762</lpage><pub-id pub-id-type="doi">10.4239/wjd.v5.i6.756</pub-id><pub-id pub-id-type="pmid">25512778</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bauer</surname><given-names>T</given-names></name><name><surname>Zagórska</surname><given-names>A</given-names></name><name><surname>Jurkin</surname><given-names>J</given-names></name><name><surname>Yasmin</surname><given-names>N</given-names></name><name><surname>Köffel</surname><given-names>R</given-names></name><name><surname>Richter</surname><given-names>S</given-names></name><name><surname>Gesslbauer</surname><given-names>B</given-names></name><name><surname>Lemke</surname><given-names>G</given-names></name><name><surname>Strobl</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Identification of Axl as a downstream effector of TGF-β1 during Langerhans cell differentiation and epidermal homeostasis</article-title><source>The Journal of Experimental Medicine</source><volume>209</volume><fpage>2033</fpage><lpage>2047</lpage><pub-id pub-id-type="doi">10.1084/jem.20120493</pub-id><pub-id pub-id-type="pmid">23071254</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bosurgi</surname><given-names>L</given-names></name><name><surname>Cao</surname><given-names>YG</given-names></name><name><surname>Cabeza-Cabrerizo</surname><given-names>M</given-names></name><name><surname>Tucci</surname><given-names>A</given-names></name><name><surname>Hughes</surname><given-names>LD</given-names></name><name><surname>Kong</surname><given-names>Y</given-names></name><name><surname>Weinstein</surname><given-names>JS</given-names></name><name><surname>Licona-Limon</surname><given-names>P</given-names></name><name><surname>Schmid</surname><given-names>ET</given-names></name><name><surname>Pelorosso</surname><given-names>F</given-names></name><name><surname>Gagliani</surname><given-names>N</given-names></name><name><surname>Craft</surname><given-names>JE</given-names></name><name><surname>Flavell</surname><given-names>RA</given-names></name><name><surname>Ghosh</surname><given-names>S</given-names></name><name><surname>Rothlin</surname><given-names>CV</given-names></name></person-group><year iso-8601-date="2017">2017a</year><article-title>Macrophage function in tissue repair and remodeling requires IL-4 or IL-13 with apoptotic cells</article-title><source>Science</source><volume>356</volume><fpage>1072</fpage><lpage>1076</lpage><pub-id pub-id-type="doi">10.1126/science.aai8132</pub-id><pub-id pub-id-type="pmid">28495875</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bosurgi</surname><given-names>L</given-names></name><name><surname>Hughes</surname><given-names>LD</given-names></name><name><surname>Rothlin</surname><given-names>CV</given-names></name><name><surname>Ghosh</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2017">2017b</year><article-title>Death begets a new beginning</article-title><source>Immunological Reviews</source><volume>280</volume><fpage>8</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1111/imr.12585</pub-id><pub-id pub-id-type="pmid">29027219</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brand</surname><given-names>TM</given-names></name><name><surname>Iida</surname><given-names>M</given-names></name><name><surname>Stein</surname><given-names>AP</given-names></name><name><surname>Corrigan</surname><given-names>KL</given-names></name><name><surname>Braverman</surname><given-names>CM</given-names></name><name><surname>Luthar</surname><given-names>N</given-names></name><name><surname>Toulany</surname><given-names>M</given-names></name><name><surname>Gill</surname><given-names>PS</given-names></name><name><surname>Salgia</surname><given-names>R</given-names></name><name><surname>Kimple</surname><given-names>RJ</given-names></name><name><surname>Wheeler</surname><given-names>DL</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>AXL mediates resistance to cetuximab therapy</article-title><source>Cancer Research</source><volume>74</volume><fpage>5152</fpage><lpage>5164</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-14-0294</pub-id><pub-id pub-id-type="pmid">25136066</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bridges</surname><given-names>K</given-names></name><name><surname>Miller-Jensen</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Mapping and Validation of scRNA-Seq-Derived Cell-Cell Communication Networks in the Tumor Microenvironment</article-title><source>Frontiers in Immunology</source><volume>13</volume><elocation-id>885267</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2022.885267</pub-id><pub-id pub-id-type="pmid">35572582</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Codispoti</surname><given-names>B</given-names></name><name><surname>Makeeva</surname><given-names>I</given-names></name><name><surname>Sied</surname><given-names>J</given-names></name><name><surname>Benincasa</surname><given-names>C</given-names></name><name><surname>Scacco</surname><given-names>S</given-names></name><name><surname>Tatullo</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Should we reconsider the apoptosis as a strategic player in tissue regeneration?</article-title><source>International Journal of Biological Sciences</source><volume>15</volume><fpage>2029</fpage><lpage>2036</lpage><pub-id pub-id-type="doi">10.7150/ijbs.36362</pub-id><pub-id pub-id-type="pmid">31592227</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dick</surname><given-names>SA</given-names></name><name><surname>Macklin</surname><given-names>JA</given-names></name><name><surname>Nejat</surname><given-names>S</given-names></name><name><surname>Momen</surname><given-names>A</given-names></name><name><surname>Clemente-Casares</surname><given-names>X</given-names></name><name><surname>Althagafi</surname><given-names>MG</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Kantores</surname><given-names>C</given-names></name><name><surname>Hosseinzadeh</surname><given-names>S</given-names></name><name><surname>Aronoff</surname><given-names>L</given-names></name><name><surname>Wong</surname><given-names>A</given-names></name><name><surname>Zaman</surname><given-names>R</given-names></name><name><surname>Barbu</surname><given-names>I</given-names></name><name><surname>Besla</surname><given-names>R</given-names></name><name><surname>Lavine</surname><given-names>KJ</given-names></name><name><surname>Razani</surname><given-names>B</given-names></name><name><surname>Ginhoux</surname><given-names>F</given-names></name><name><surname>Husain</surname><given-names>M</given-names></name><name><surname>Cybulsky</surname><given-names>MI</given-names></name><name><surname>Robbins</surname><given-names>CS</given-names></name><name><surname>Epelman</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Publisher Correction: Self-renewing resident cardiac macrophages limit adverse remodeling following myocardial infarction</article-title><source>Nature Immunology</source><volume>20</volume><elocation-id>664</elocation-id><pub-id pub-id-type="doi">10.1038/s41590-019-0363-8</pub-id><pub-id pub-id-type="pmid">30862954</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elliott</surname><given-names>MR</given-names></name><name><surname>Koster</surname><given-names>KM</given-names></name><name><surname>Murphy</surname><given-names>PS</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Efferocytosis signaling in the regulation of macrophage inflammatory responses</article-title><source>Journal of Immunology</source><volume>198</volume><fpage>1387</fpage><lpage>1394</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1601520</pub-id><pub-id pub-id-type="pmid">28167649</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elmore</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Apoptosis: a review of programmed cell death</article-title><source>Toxicologic Pathology</source><volume>35</volume><fpage>495</fpage><lpage>516</lpage><pub-id pub-id-type="doi">10.1080/01926230701320337</pub-id><pub-id pub-id-type="pmid">17562483</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eming</surname><given-names>SA</given-names></name><name><surname>Martin</surname><given-names>P</given-names></name><name><surname>Tomic-Canic</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Wound repair and regeneration: mechanisms, signaling, and translation</article-title><source>Science Translational Medicine</source><volume>6</volume><elocation-id>265sr6</elocation-id><pub-id pub-id-type="doi">10.1126/scitranslmed.3009337</pub-id><pub-id pub-id-type="pmid">25473038</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Foks</surname><given-names>AC</given-names></name><name><surname>Engelbertsen</surname><given-names>D</given-names></name><name><surname>Kuperwaser</surname><given-names>F</given-names></name><name><surname>Alberts-Grill</surname><given-names>N</given-names></name><name><surname>Gonen</surname><given-names>A</given-names></name><name><surname>Witztum</surname><given-names>JL</given-names></name><name><surname>Lederer</surname><given-names>J</given-names></name><name><surname>Jarolim</surname><given-names>P</given-names></name><name><surname>DeKruyff</surname><given-names>RH</given-names></name><name><surname>Freeman</surname><given-names>GJ</given-names></name><name><surname>Lichtman</surname><given-names>AH</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Blockade of Tim-1 and Tim-4 Enhances Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice</article-title><source>Arteriosclerosis, Thrombosis, and Vascular Biology</source><volume>36</volume><fpage>456</fpage><lpage>465</lpage><pub-id pub-id-type="doi">10.1161/ATVBAHA.115.306860</pub-id><pub-id pub-id-type="pmid">26821944</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fuchs</surname><given-names>Y</given-names></name><name><surname>Brown</surname><given-names>S</given-names></name><name><surname>Gorenc</surname><given-names>T</given-names></name><name><surname>Rodriguez</surname><given-names>J</given-names></name><name><surname>Fuchs</surname><given-names>E</given-names></name><name><surname>Steller</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Sept4/ARTS regulates stem cell apoptosis and skin regeneration</article-title><source>Science</source><volume>341</volume><fpage>286</fpage><lpage>289</lpage><pub-id pub-id-type="doi">10.1126/science.1233029</pub-id><pub-id pub-id-type="pmid">23788729</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greenhalgh</surname><given-names>DG</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>The role of apoptosis in wound healing</article-title><source>The International Journal of Biochemistry &amp; Cell Biology</source><volume>30</volume><fpage>1019</fpage><lpage>1030</lpage><pub-id pub-id-type="doi">10.1016/s1357-2725(98)00058-2</pub-id><pub-id pub-id-type="pmid">9785465</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guerin</surname><given-names>DJ</given-names></name><name><surname>Kha</surname><given-names>CX</given-names></name><name><surname>Tseng</surname><given-names>KAS</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>From cell death to regeneration: rebuilding after injury</article-title><source>Frontiers in Cell and Developmental Biology</source><volume>9</volume><elocation-id>655048</elocation-id><pub-id pub-id-type="doi">10.3389/fcell.2021.655048</pub-id><pub-id pub-id-type="pmid">33816506</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haensel</surname><given-names>D</given-names></name><name><surname>Jin</surname><given-names>S</given-names></name><name><surname>Sun</surname><given-names>P</given-names></name><name><surname>Cinco</surname><given-names>R</given-names></name><name><surname>Dragan</surname><given-names>M</given-names></name><name><surname>Nguyen</surname><given-names>Q</given-names></name><name><surname>Cang</surname><given-names>Z</given-names></name><name><surname>Gong</surname><given-names>Y</given-names></name><name><surname>Vu</surname><given-names>R</given-names></name><name><surname>MacLean</surname><given-names>AL</given-names></name><name><surname>Kessenbrock</surname><given-names>K</given-names></name><name><surname>Gratton</surname><given-names>E</given-names></name><name><surname>Nie</surname><given-names>Q</given-names></name><name><surname>Dai</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Defining epidermal basal cell states during skin homeostasis and wound healing using single-cell transcriptomics</article-title><source>Cell Reports</source><volume>30</volume><fpage>3932</fpage><lpage>3947</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2020.02.091</pub-id><pub-id pub-id-type="pmid">32187560</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hie</surname><given-names>B</given-names></name><name><surname>Bryson</surname><given-names>B</given-names></name><name><surname>Berger</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Efficient integration of heterogeneous single-cell transcriptomes using Scanorama</article-title><source>Nature Biotechnology</source><volume>37</volume><fpage>685</fpage><lpage>691</lpage><pub-id pub-id-type="doi">10.1038/s41587-019-0113-3</pub-id><pub-id pub-id-type="pmid">31061482</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hwang</surname><given-names>JS</given-names></name><name><surname>Kobayashi</surname><given-names>C</given-names></name><name><surname>Agata</surname><given-names>K</given-names></name><name><surname>Ikeo</surname><given-names>K</given-names></name><name><surname>Gojobori</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Detection of apoptosis during planarian regeneration by the expression of apoptosis-related genes and TUNEL assay</article-title><source>Gene</source><volume>333</volume><fpage>15</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1016/j.gene.2004.02.034</pub-id><pub-id pub-id-type="pmid">15177676</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>S</given-names></name><name><surname>Guerrero-Juarez</surname><given-names>CF</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Chang</surname><given-names>I</given-names></name><name><surname>Ramos</surname><given-names>R</given-names></name><name><surname>Kuan</surname><given-names>CH</given-names></name><name><surname>Myung</surname><given-names>P</given-names></name><name><surname>Plikus</surname><given-names>MV</given-names></name><name><surname>Nie</surname><given-names>Q</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Inference and analysis of cell-cell communication using CellChat</article-title><source>Nature Communications</source><volume>12</volume><elocation-id>1088</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-021-21246-9</pub-id><pub-id pub-id-type="pmid">33597522</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khanna</surname><given-names>S</given-names></name><name><surname>Biswas</surname><given-names>S</given-names></name><name><surname>Shang</surname><given-names>Y</given-names></name><name><surname>Collard</surname><given-names>E</given-names></name><name><surname>Azad</surname><given-names>A</given-names></name><name><surname>Kauh</surname><given-names>C</given-names></name><name><surname>Bhasker</surname><given-names>V</given-names></name><name><surname>Gordillo</surname><given-names>GM</given-names></name><name><surname>Sen</surname><given-names>CK</given-names></name><name><surname>Roy</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Macrophage dysfunction impairs resolution of inflammation in the wounds of diabetic mice</article-title><source>PLOS ONE</source><volume>5</volume><elocation-id>e9539</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0009539</pub-id><pub-id pub-id-type="pmid">20209061</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>MP</given-names></name><name><surname>Du</surname><given-names>J</given-names></name><name><surname>Lagoudas</surname><given-names>G</given-names></name><name><surname>Jiao</surname><given-names>Y</given-names></name><name><surname>Sawyer</surname><given-names>A</given-names></name><name><surname>Drummond</surname><given-names>DC</given-names></name><name><surname>Lauffenburger</surname><given-names>DA</given-names></name><name><surname>Raue</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Analysis of Single-Cell RNA-Seq Identifies Cell-Cell Communication Associated with Tumor Characteristics</article-title><source>Cell Reports</source><volume>25</volume><fpage>1458</fpage><lpage>1468</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2018.10.047</pub-id><pub-id pub-id-type="pmid">30404002</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lemke</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>How macrophages deal with death</article-title><source>Nature Reviews. Immunology</source><volume>19</volume><fpage>539</fpage><lpage>549</lpage><pub-id pub-id-type="doi">10.1038/s41577-019-0167-y</pub-id><pub-id pub-id-type="pmid">31019284</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lew</surname><given-names>ED</given-names></name><name><surname>Oh</surname><given-names>J</given-names></name><name><surname>Burrola</surname><given-names>PG</given-names></name><name><surname>Lax</surname><given-names>I</given-names></name><name><surname>Zagórska</surname><given-names>A</given-names></name><name><surname>Través</surname><given-names>PG</given-names></name><name><surname>Schlessinger</surname><given-names>J</given-names></name><name><surname>Lemke</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Differential TAM receptor-ligand-phospholipid interactions delimit differential TAM bioactivities</article-title><source>eLife</source><volume>3</volume><elocation-id>e03385</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.03385</pub-id><pub-id pub-id-type="pmid">25265470</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Ye</surname><given-names>X</given-names></name><name><surname>Tan</surname><given-names>C</given-names></name><name><surname>Hongo</surname><given-names>JA</given-names></name><name><surname>Zha</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Kallop</surname><given-names>D</given-names></name><name><surname>Ludlam</surname><given-names>MJC</given-names></name><name><surname>Pei</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Axl as a potential therapeutic target in cancer: role of Axl in tumor growth, metastasis and angiogenesis</article-title><source>Oncogene</source><volume>28</volume><fpage>3442</fpage><lpage>3455</lpage><pub-id pub-id-type="doi">10.1038/onc.2009.212</pub-id><pub-id pub-id-type="pmid">19633687</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>F</given-names></name><name><surname>Huang</surname><given-names>Q</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Peng</surname><given-names>Y</given-names></name><name><surname>Roop</surname><given-names>D</given-names></name><name><surname>Bedford</surname><given-names>JS</given-names></name><name><surname>Li</surname><given-names>CY</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Apoptotic cells activate the phoenix rising pathway</article-title><source>Science Signaling</source><volume>3</volume><elocation-id>ra13</elocation-id><pub-id pub-id-type="doi">10.1126/scisignal.2000634.Apoptotic</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>HY</given-names></name><name><surname>Lim</surname><given-names>SY</given-names></name><name><surname>Tan</surname><given-names>CK</given-names></name><name><surname>Thiam</surname><given-names>CH</given-names></name><name><surname>Goh</surname><given-names>CC</given-names></name><name><surname>Carbajo</surname><given-names>D</given-names></name><name><surname>Chew</surname><given-names>SHS</given-names></name><name><surname>See</surname><given-names>P</given-names></name><name><surname>Chakarov</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>XN</given-names></name><name><surname>Lim</surname><given-names>LH</given-names></name><name><surname>Johnson</surname><given-names>LA</given-names></name><name><surname>Lum</surname><given-names>J</given-names></name><name><surname>Fong</surname><given-names>CY</given-names></name><name><surname>Bongso</surname><given-names>A</given-names></name><name><surname>Biswas</surname><given-names>A</given-names></name><name><surname>Goh</surname><given-names>C</given-names></name><name><surname>Evrard</surname><given-names>M</given-names></name><name><surname>Yeo</surname><given-names>KP</given-names></name><name><surname>Basu</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>JK</given-names></name><name><surname>Tan</surname><given-names>Y</given-names></name><name><surname>Jain</surname><given-names>R</given-names></name><name><surname>Tikoo</surname><given-names>S</given-names></name><name><surname>Choong</surname><given-names>C</given-names></name><name><surname>Weninger</surname><given-names>W</given-names></name><name><surname>Poidinger</surname><given-names>M</given-names></name><name><surname>Stanley</surname><given-names>ER</given-names></name><name><surname>Collin</surname><given-names>M</given-names></name><name><surname>Tan</surname><given-names>NS</given-names></name><name><surname>Ng</surname><given-names>LG</given-names></name><name><surname>Jackson</surname><given-names>DG</given-names></name><name><surname>Ginhoux</surname><given-names>F</given-names></name><name><surname>Angeli</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Hyaluronan receptor LYVE-1-expressing macrophages maintain arterial tone through hyaluronan-mediated regulation of smooth muscle cell collagen</article-title><source>Immunity</source><volume>49</volume><elocation-id>1191</elocation-id><pub-id pub-id-type="doi">10.1016/j.immuni.2018.12.009</pub-id><pub-id pub-id-type="pmid">30566884</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>Q</given-names></name><name><surname>Fang</surname><given-names>D</given-names></name><name><surname>Fang</surname><given-names>J</given-names></name><name><surname>Ren</surname><given-names>X</given-names></name><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Wen</surname><given-names>F</given-names></name><name><surname>Su</surname><given-names>SB</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Impaired wound healing with defective expression of chemokines and recruitment of myeloid cells in TLR3-deficient mice</article-title><source>Journal of Immunology</source><volume>186</volume><fpage>3710</fpage><lpage>3717</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1003007</pub-id><pub-id pub-id-type="pmid">21317384</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Linger</surname><given-names>RMA</given-names></name><name><surname>Keating</surname><given-names>AK</given-names></name><name><surname>Earp</surname><given-names>HS</given-names></name><name><surname>Graham</surname><given-names>DK</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer</article-title><source>Advances in Cancer Research</source><volume>100</volume><fpage>35</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1016/S0065-230X(08)00002-X</pub-id><pub-id pub-id-type="pmid">18620092</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>McInnes</surname><given-names>L</given-names></name><name><surname>Healy</surname><given-names>J</given-names></name><name><surname>Melville</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>UMAP: Uniform Manifold Approximation and Projection for Dimension Reduction</article-title><source>arXiv</source><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.48550/arXiv.1802.03426">https://doi.org/10.48550/arXiv.1802.03426</ext-link></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meyer</surname><given-names>AS</given-names></name><name><surname>Miller</surname><given-names>MA</given-names></name><name><surname>Gertler</surname><given-names>FB</given-names></name><name><surname>Lauffenburger</surname><given-names>DA</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The receptor AXL diversifies EGFR signaling and limits the response to EGFR-targeted inhibitors in triple-negative breast cancer cells</article-title><source>Science Signaling</source><volume>6</volume><elocation-id>ra66</elocation-id><pub-id pub-id-type="doi">10.1126/scisignal.2004155</pub-id><pub-id pub-id-type="pmid">23921085</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ouyang</surname><given-names>JF</given-names></name><name><surname>Kamaraj</surname><given-names>US</given-names></name><name><surname>Cao</surname><given-names>EY</given-names></name><name><surname>Rackham</surname><given-names>OJL</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>ShinyCell: simple and sharable visualization of single-cell gene expression data</article-title><source>Bioinformatics</source><volume>37</volume><fpage>3374</fpage><lpage>3376</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btab209</pub-id><pub-id pub-id-type="pmid">33774659</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peiseler</surname><given-names>M</given-names></name><name><surname>Kubes</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>More friend than foe: the emerging role of neutrophils in tissue repair</article-title><source>The Journal of Clinical Investigation</source><volume>129</volume><fpage>2629</fpage><lpage>2639</lpage><pub-id pub-id-type="doi">10.1172/JCI124616</pub-id><pub-id pub-id-type="pmid">31205028</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raudvere</surname><given-names>U</given-names></name><name><surname>Kolberg</surname><given-names>L</given-names></name><name><surname>Kuzmin</surname><given-names>I</given-names></name><name><surname>Arak</surname><given-names>T</given-names></name><name><surname>Adler</surname><given-names>P</given-names></name><name><surname>Peterson</surname><given-names>H</given-names></name><name><surname>Vilo</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>g:Profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update)</article-title><source>Nucleic Acids Research</source><volume>47</volume><fpage>W191</fpage><lpage>W198</lpage><pub-id pub-id-type="doi">10.1093/nar/gkz369</pub-id><pub-id pub-id-type="pmid">31066453</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Retallack</surname><given-names>H</given-names></name><name><surname>Di Lullo</surname><given-names>E</given-names></name><name><surname>Arias</surname><given-names>C</given-names></name><name><surname>Knopp</surname><given-names>KA</given-names></name><name><surname>Laurie</surname><given-names>MT</given-names></name><name><surname>Sandoval-Espinosa</surname><given-names>C</given-names></name><name><surname>Mancia Leon</surname><given-names>WR</given-names></name><name><surname>Krencik</surname><given-names>R</given-names></name><name><surname>Ullian</surname><given-names>EM</given-names></name><name><surname>Spatazza</surname><given-names>J</given-names></name><name><surname>Pollen</surname><given-names>AA</given-names></name><name><surname>Mandel-Brehm</surname><given-names>C</given-names></name><name><surname>Nowakowski</surname><given-names>TJ</given-names></name><name><surname>Kriegstein</surname><given-names>AR</given-names></name><name><surname>DeRisi</surname><given-names>JL</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Zika virus cell tropism in the developing human brain and inhibition by azithromycin</article-title><source>PNAS</source><volume>113</volume><fpage>14408</fpage><lpage>14413</lpage><pub-id pub-id-type="doi">10.1073/pnas.1618029113</pub-id><pub-id pub-id-type="pmid">27911847</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rios</surname><given-names>FJ</given-names></name><name><surname>Touyz</surname><given-names>RM</given-names></name><name><surname>Montezano</surname><given-names>AC</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Isolation and differentiation of human macrophages</article-title><source>Methods in Molecular Biology</source><volume>1527</volume><fpage>311</fpage><lpage>320</lpage><pub-id pub-id-type="doi">10.1007/978-1-4939-6625-7_24</pub-id><pub-id pub-id-type="pmid">28116726</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romana-Souza</surname><given-names>B</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Leonardo</surname><given-names>TR</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>DiPietro</surname><given-names>LA</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Dermal fibroblast phagocytosis of apoptotic cells: a novel pathway for wound resolution</article-title><source>FASEB Journal</source><volume>35</volume><elocation-id>e21443</elocation-id><pub-id pub-id-type="doi">10.1096/fj.202002078R</pub-id><pub-id pub-id-type="pmid">33749877</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rothlin</surname><given-names>CV</given-names></name><name><surname>Ghosh</surname><given-names>S</given-names></name><name><surname>Zuniga</surname><given-names>EI</given-names></name><name><surname>Oldstone</surname><given-names>MBA</given-names></name><name><surname>Lemke</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>TAM receptors are pleiotropic inhibitors of the innate immune response</article-title><source>Cell</source><volume>131</volume><fpage>1124</fpage><lpage>1136</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2007.10.034</pub-id><pub-id pub-id-type="pmid">18083102</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rothlin</surname><given-names>CV</given-names></name><name><surname>Ghosh</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Cracking the cell death code</article-title><source>Cold Spring Harbor Perspectives in Biology</source><volume>12</volume><elocation-id>a036343</elocation-id><pub-id pub-id-type="doi">10.1101/cshperspect.a036343</pub-id><pub-id pub-id-type="pmid">31548182</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmidt</surname><given-names>BA</given-names></name><name><surname>Horsley</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Intradermal adipocytes mediate fibroblast recruitment during skin wound healing</article-title><source>Development</source><volume>140</volume><fpage>1517</fpage><lpage>1527</lpage><pub-id pub-id-type="doi">10.1242/dev.087593</pub-id><pub-id pub-id-type="pmid">23482487</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shook</surname><given-names>B</given-names></name><name><surname>Xiao</surname><given-names>E</given-names></name><name><surname>Kumamoto</surname><given-names>Y</given-names></name><name><surname>Iwasaki</surname><given-names>A</given-names></name><name><surname>Horsley</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>CD301b+ Macrophages Are Essential for Effective Skin Wound Healing</article-title><source>The Journal of Investigative Dermatology</source><volume>136</volume><fpage>1885</fpage><lpage>1891</lpage><pub-id pub-id-type="doi">10.1016/j.jid.2016.05.107</pub-id><pub-id pub-id-type="pmid">27287183</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shook</surname><given-names>BA</given-names></name><name><surname>Wasko</surname><given-names>RR</given-names></name><name><surname>Rivera-Gonzalez</surname><given-names>GC</given-names></name><name><surname>Salazar-Gatzimas</surname><given-names>E</given-names></name><name><surname>López-Giráldez</surname><given-names>F</given-names></name><name><surname>Dash</surname><given-names>BC</given-names></name><name><surname>Muñoz-Rojas</surname><given-names>AR</given-names></name><name><surname>Aultman</surname><given-names>KD</given-names></name><name><surname>Zwick</surname><given-names>RK</given-names></name><name><surname>Lei</surname><given-names>V</given-names></name><name><surname>Arbiser</surname><given-names>JL</given-names></name><name><surname>Miller-Jensen</surname><given-names>K</given-names></name><name><surname>Clark</surname><given-names>DA</given-names></name><name><surname>Hsia</surname><given-names>HC</given-names></name><name><surname>Horsley</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Myofibroblast proliferation and heterogeneity are supported by macrophages during skin repair</article-title><source>Science</source><volume>362</volume><elocation-id>eaar2971</elocation-id><pub-id pub-id-type="doi">10.1126/science.aar2971</pub-id><pub-id pub-id-type="pmid">30467144</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thornley</surname><given-names>TB</given-names></name><name><surname>Fang</surname><given-names>Z</given-names></name><name><surname>Balasubramanian</surname><given-names>S</given-names></name><name><surname>Larocca</surname><given-names>RA</given-names></name><name><surname>Gong</surname><given-names>W</given-names></name><name><surname>Gupta</surname><given-names>S</given-names></name><name><surname>Csizmadia</surname><given-names>E</given-names></name><name><surname>Degauque</surname><given-names>N</given-names></name><name><surname>Kim</surname><given-names>BS</given-names></name><name><surname>Koulmanda</surname><given-names>M</given-names></name><name><surname>Kuchroo</surname><given-names>VK</given-names></name><name><surname>Strom</surname><given-names>TB</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Fragile TIM-4-expressing tissue resident macrophages are migratory and immunoregulatory</article-title><source>The Journal of Clinical Investigation</source><volume>124</volume><fpage>3443</fpage><lpage>3454</lpage><pub-id pub-id-type="doi">10.1172/JCI73527</pub-id><pub-id pub-id-type="pmid">24983317</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tseng</surname><given-names>AS</given-names></name><name><surname>Adams</surname><given-names>DS</given-names></name><name><surname>Qiu</surname><given-names>D</given-names></name><name><surname>Koustubhan</surname><given-names>P</given-names></name><name><surname>Levin</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Apoptosis is required during early stages of tail regeneration in <italic>Xenopus laevis</italic></article-title><source>Developmental Biology</source><volume>301</volume><fpage>62</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2006.10.048</pub-id><pub-id pub-id-type="pmid">17150209</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Chaffee</surname><given-names>TS</given-names></name><name><surname>LaRue</surname><given-names>RS</given-names></name><name><surname>Huggins</surname><given-names>DN</given-names></name><name><surname>Witschen</surname><given-names>PM</given-names></name><name><surname>Ibrahim</surname><given-names>AM</given-names></name><name><surname>Nelson</surname><given-names>AC</given-names></name><name><surname>Machado</surname><given-names>HL</given-names></name><name><surname>Schwertfeger</surname><given-names>KL</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Tissue-resident macrophages promote extracellular matrix homeostasis in the mammary gland stroma of nulliparous mice</article-title><source>eLife</source><volume>9</volume><elocation-id>57438</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.57438</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>YT</given-names></name><name><surname>Trzeciak</surname><given-names>AJ</given-names></name><name><surname>Rojas</surname><given-names>WS</given-names></name><name><surname>Saavedra</surname><given-names>P</given-names></name><name><surname>Chen</surname><given-names>YT</given-names></name><name><surname>Chirayil</surname><given-names>R</given-names></name><name><surname>Etchegaray</surname><given-names>JI</given-names></name><name><surname>Lucas</surname><given-names>CD</given-names></name><name><surname>Puleston</surname><given-names>DJ</given-names></name><name><surname>Keshari</surname><given-names>KR</given-names></name><name><surname>Perry</surname><given-names>JSA</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Metabolic adaptation supports enhanced macrophage efferocytosis in limited-oxygen environments</article-title><source>Cell Metabolism</source><volume>35</volume><fpage>316</fpage><lpage>331</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2022.12.005</pub-id><pub-id pub-id-type="pmid">36584675</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wasko</surname><given-names>R</given-names></name><name><surname>Bridges</surname><given-names>K</given-names></name><name><surname>Pannone</surname><given-names>R</given-names></name><name><surname>Sidhu</surname><given-names>I</given-names></name><name><surname>Xing</surname><given-names>Y</given-names></name><name><surname>Naik</surname><given-names>S</given-names></name><name><surname>Miller-Jensen</surname><given-names>K</given-names></name><name><surname>Horsley</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Langerhans cells are essential components of the angiogenic niche during murine skin repair</article-title><source>Developmental Cell</source><volume>57</volume><fpage>2699</fpage><lpage>2713</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2022.11.012</pub-id><pub-id pub-id-type="pmid">36493773</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>C</given-names></name><name><surname>Ye</surname><given-names>X</given-names></name><name><surname>Pham</surname><given-names>T</given-names></name><name><surname>Lin</surname><given-names>E</given-names></name><name><surname>Chan</surname><given-names>S</given-names></name><name><surname>McNamara</surname><given-names>E</given-names></name><name><surname>Neve</surname><given-names>RM</given-names></name><name><surname>Belmont</surname><given-names>L</given-names></name><name><surname>Koeppen</surname><given-names>H</given-names></name><name><surname>Yauch</surname><given-names>RL</given-names></name><name><surname>Ashkenazi</surname><given-names>A</given-names></name><name><surname>Settleman</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>AXL inhibition sensitizes mesenchymal cancer cells to antimitotic drugs</article-title><source>Cancer Research</source><volume>74</volume><fpage>5878</fpage><lpage>5890</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-14-1009</pub-id><pub-id pub-id-type="pmid">25125659</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolf</surname><given-names>FA</given-names></name><name><surname>Angerer</surname><given-names>P</given-names></name><name><surname>Theis</surname><given-names>FJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>SCANPY: large-scale single-cell gene expression data analysis</article-title><source>Genome Biology</source><volume>19</volume><elocation-id>15</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-017-1382-0</pub-id><pub-id pub-id-type="pmid">29409532</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yeung</surname><given-names>MY</given-names></name><name><surname>McGrath</surname><given-names>MM</given-names></name><name><surname>Nakayama</surname><given-names>M</given-names></name><name><surname>Shimizu</surname><given-names>T</given-names></name><name><surname>Boenisch</surname><given-names>O</given-names></name><name><surname>Magee</surname><given-names>CN</given-names></name><name><surname>Abdoli</surname><given-names>R</given-names></name><name><surname>Akiba</surname><given-names>H</given-names></name><name><surname>Ueno</surname><given-names>T</given-names></name><name><surname>Turka</surname><given-names>LA</given-names></name><name><surname>Najafian</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Interruption of dendritic cell-mediated TIM-4 signaling induces regulatory T cells and promotes skin allograft survival</article-title><source>Journal of Immunology</source><volume>191</volume><fpage>4447</fpage><lpage>4455</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1300992</pub-id><pub-id pub-id-type="pmid">24038092</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yui</surname><given-names>S</given-names></name><name><surname>Nakatani</surname><given-names>Y</given-names></name><name><surname>Mikami</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Calprotectin (S100A8/S100A9), an inflammatory protein complex from neutrophils with a broad apoptosis-inducing activity</article-title><source>Biological &amp; Pharmaceutical Bulletin</source><volume>26</volume><fpage>753</fpage><lpage>760</lpage><pub-id pub-id-type="doi">10.1248/bpb.26.753</pub-id><pub-id pub-id-type="pmid">12808281</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zagórska</surname><given-names>A</given-names></name><name><surname>Través</surname><given-names>PG</given-names></name><name><surname>Lew</surname><given-names>ED</given-names></name><name><surname>Dransfield</surname><given-names>I</given-names></name><name><surname>Lemke</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Diversification of TAM receptor tyrosine kinase function</article-title><source>Nature Immunology</source><volume>15</volume><fpage>920</fpage><lpage>928</lpage><pub-id pub-id-type="doi">10.1038/ni.2986</pub-id><pub-id pub-id-type="pmid">25194421</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>C</given-names></name><name><surname>Wei</surname><given-names>Y</given-names></name><name><surname>Wei</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>AXL receptor tyrosine kinase as a promising anti-cancer approach: functions, molecular mechanisms and clinical applications</article-title><source>Molecular Cancer</source><volume>18</volume><elocation-id>153</elocation-id><pub-id pub-id-type="doi">10.1186/s12943-019-1090-3</pub-id><pub-id pub-id-type="pmid">31684958</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.86269.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Jamora</surname><given-names>Colin</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/007wpch15</institution-id><institution>Institute for Stem Cell Biology and Regenerative Medicine</institution></institution-wrap><country>India</country></aff></contrib></contrib-group><related-object id="sa0ro1" object-id-type="id" object-id="10.1101/2023.01.17.523241" link-type="continued-by" xlink:href="https://sciety.org/articles/activity/10.1101/2023.01.17.523241"/></front-stub><body><p>The manuscript reports important new information on how dead cells are cleared from the wound site in order to promote effective repair of the damaged tissue. Interestingly, the authors find that the components of this clearance pathway are abnormally high in diabetics who have difficulty healing wounds and their results suggest that tampering them down may be a therapy to restore normal wound healing.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.86269.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Jamora</surname><given-names>Colin</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/007wpch15</institution-id><institution>Institute for Stem Cell Biology and Regenerative Medicine</institution></institution-wrap><country>India</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>Our editorial process produces two outputs: (i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2023.01.17.523241">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2023.01.17.523241v1">the preprint</ext-link> for the benefit of readers; (ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Apoptosis recognition receptors regulate skin tissue repair in mice&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 3 peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by Satyajit Rath as the Senior Editor.</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions:</p><p>Overall, the reviewers are uniform in finding the manuscript a valuable contribution to the field and generally solid in methodology. However, there were a few consistent points that the technical rigor of the manuscript needs to be improved in order to better support the conclusions that are drawn from them. For instance, the suggested additional experiments are relatively straightforward and would substantially improve the data:</p><p>1. Quantify the apoptotic cells observed in the sections (Figure 1 I and J) and compare to control treatment on sections. It is not clear from the data presented whether the number of apoptotic cells increases or not in the time frame analyzed since the controls are lacking.</p><p>2. In a similar vein, it would be important to demonstrate in their system that there is actually an increase in apoptotic cells in the wounds. This data is absent and the inclusion of this would provide temporal insights into the initiation and speed of efferocytosis.</p><p>3. Conclusions based on CellChat analysis should be experimentally validated.</p><p><italic>Reviewer #1 (Recommendations for the authors):</italic></p><p>More recent datasets of efferocytosis related genes involved in diabetic wound healing such as SLC7 gene family members could be included in the analysis as it has direct bearing on the work.</p><p>The inhibition of Axl seems to have a dramatic effect scab formation, fibroblast representation in the wound bed, and vascularization but no significant effect on wound closure rates. This is a surprising observation and perhaps too much weight is given to ITGA6 staining and other assays of reepithelialization should be assessed. In addition, the potential therapeutic applications that the authors note for chronic wounds suggest that they should test the physiological parameters of the healed skin to determine how &quot;normal&quot; it truly is.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.86269.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>Overall, the reviewers are uniform in finding the manuscript a valuable contribution to the field and generally solid in methodology. However, there were a few consistent points that the technical rigor of the manuscript needs to be improved in order to better support the conclusions that are drawn from them. For instance, the suggested additional experiments are relatively straightforward and would substantially improve the data:</p><p>1. Quantify the apoptotic cells observed in the sections (Figure 1 I and J) and compare to control treatment on sections. It is not clear from the data presented whether the number of apoptotic cells increases or not in the time frame analyzed since the controls are lacking.</p></disp-quote><p>We thank the editors and reviewers for this important comment. We have repeated this staining experiment with the recommended antibody for cleaved (active) caspase 3. These data are now included in Figures 1H-J and Figure 1 – figure supplement 1F. While these were untreated samples, we were able to quantify the apoptotic cells visible by cleaved caspase 3 staining in 24h and 48h wounds. We found that, when quantified via IF staining, the apoptotic cells visible in the wound bed significantly increased between 24h and 48h after injury (Figure 1 – figure supplement 1F).</p><disp-quote content-type="editor-comment"><p>2. In a similar vein, it would be important to demonstrate in their system that there is actually an increase in apoptotic cells in the wounds. This data is absent and the inclusion of this would provide temporal insights into the initiation and speed of efferocytosis.</p></disp-quote><p>Thank you for this interesting and important suggestion. To analyze the initiation and speed of efferocytosis, we injected labeled apoptotic neutrophils into the wound bed at 1, 3, and 5 days after injury. 1 hour after this injection, we collected the wound beds for sectioning and staining and quantified the stained cells (either whole neutrophils or neutrophils undergoing efferocytosis) remaining in each wound bed. We found that significantly more neutrophils undergoing efferocytosis remained in 5D wound beds and that the rate of efferocytosis (calculated by dividing stained cells in efferocytosis by all stained cells) was constant over time, indicating that efferocytosis is active throughout the inflammatory and proliferative phases of wound healing. These data are now included in Figures 2H-M.</p><disp-quote content-type="editor-comment"><p>3. Conclusions based on CellChat analysis should be experimentally validated.</p></disp-quote><p>Thank you for this suggestion. We have compared the presence of Gas6 and Gas6<sup>+</sup> macrophages in diabetic and nondiabetic human wounds via IF staining and found that, in accordance with the CellChat analysis, more macrophage Gas6 expression is observed in diabetic wounds. These data are included in Figures 3C-D.</p><disp-quote content-type="editor-comment"><p>Reviewer #1 (Recommendations for the authors):</p><p>More recent datasets of efferocytosis related genes involved in diabetic wound healing such as SLC7 gene family members could be included in the analysis as it has direct bearing on the work.</p></disp-quote><p>Thank you for this helpful suggestion. We have included <italic>Slc7a11</italic> in the single-cell heatmaps in Figures 2A and Figure 3 – figure supplement 1A, as well as in the qPCR experiments in Figure 2 – Figure supplement 1B.</p><disp-quote content-type="editor-comment"><p>The inhibition of Axl seems to have a dramatic effect scab formation, fibroblast representation in the wound bed, and vascularization but no significant effect on wound closure rates. This is a surprising observation and perhaps too much weight is given to ITGA6 staining and other assays of reepithelialization should be assessed. In addition, the potential therapeutic applications that the authors note for chronic wounds suggest that they should test the physiological parameters of the healed skin to determine how &quot;normal&quot; it truly is.</p></disp-quote><p>Thank you for this suggestion. We have altered the text in lines 307-309 to specify the phenotype indicated by ITGA6 staining to give less weight to this result. We have also altered the sentence about therapeutic applications in lines 419-422 to indicate the need for further research.</p></body></sub-article></article>